Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Instructor of Surgery, Surgery, Harvard University - 1996
  • M.D., University of Virginia 1984
• 

  Previous Appointments & Affiliations

  • Assistant Professor of Pathology, Pathology, Clinical Science Departments 2000 - 2005
  • Associate Professor of Surgery with Tenure, Surgery, Cardiovascular and Thoracic Surgery, Surgery 2000 - 2003
  • Assistant Clinical Professor of Pathology, Pathology, Clinical Science Departments 1997 - 2000
  • Associate Professor of Surgery, Surgery, Cardiovascular and Thoracic Surgery, Surgery 1997 - 2000
  • Associate Clinical Professor of Surgery, Surgery, Cardiovascular and Thoracic Surgery, Surgery 1996 - 1997
  • Instructor, Temporary in the Department of Surgery, Surgery, Cardiovascular and Thoracic Surgery, Surgery 1996
• Research
• 

  Selected Grants

  • Translational Research in Surgical Oncology awarded by National Institutes of Health 2002 - 2022
  • Duke Resident Physician-Scientist Program - NIAID awarded by National Institutes of Health 2018 - 2022
  • Prospective Validation of Prognostic and Predictive Molecular tests in Mesothelioma awarded by Brigham and Women's Hospital 2017 - 2022
  • Duke Resident Physician-Scientist Program- NHLBI awarded by National Institutes of Health 2018 - 2022
  • Military Exposure-Related Pleural Mesothelioma: An Innovative Translational Approach to Inform Novel Molecular-Targeted Treatment Development awarded by Department of Defense 2017 - 2021
  • A Retrospective Study of the myPlan Lung Cancer Test and Prediction of Chemotherapy Benefit in Patients with Early Stage Lung Adenocarcinoma awarded by Myriad Genetics, Inc. 2016 - 2021
  • Elucidating the Genome of Large Cell Lung Neuroendocrine Cancer awarded by Thoracic Surgery Foundation for Research and Education 2019 - 2020
  • IPA for Tracey Taylor awarded by Durham Veterans Affairs Medical Center 2018 - 2020
  • Lung Squamous Cell Carcinoma: Validation of Molecular Signatures of Prognosis awarded by University of Colorado - Denver 2012 - 2017
  • Clinical Oncology Research Career Development Program awarded by National Institutes of Health 2009 - 2015
  • GSK2302032A Antigen-Specific cancer Immunotherapeutic as adjuvant therapy in patients with Non-Small Cell Lung Cancer awarded by GlaxoSmithKline 2013 - 2015
  • IPA - Joshi awarded by Veterans Administration Medical Center 2011 - 2013
  • IPA - Debbie Conlon awarded by Durham Veterans Affairs Medical Center 2012 - 2013
  • Validating Molecular Signature Risk Models of NSCLC awarded by National Institutes of Health 2006 - 2012
  • Refining and Validating Genomic Signatures in Lung Cancer awarded by National Institutes of Health 2009 - 2010
  • Prospective Validation of Genomic Signatures of Chemosensitivity in NSCLC awarded by National Institutes of Health 2009 - 2010
  • Semiparametric ROC Curve Regression for Cancer Screening Studies awarded by National Institutes of Health 2007 - 2010
  • Tissue and serum indicators of lung cancer recurrence. awarded by National Institutes of Health 1996 - 2002
  • Tissue And Serum Indicators Of Lung Cancer Recurrence awarded by National Institutes of Health 1996 - 1999
• 

  External Relationships

  • AstraZeneca
  • Medtronic (Covidien)
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Browndyke, Jeffrey N., Mary C. Wright, Rosa Yang, Ayesha Syed, John Park, Ashley Hall, Katherine Martucci, et al. “Perioperative neurocognitive and functional neuroimaging trajectories in older APOE4 carriers compared with non-carriers: secondary analysis of a prospective cohort study.” Br J Anaesth 127, no. 6 (December 2021): 917–28. https://doi.org/10.1016/j.bja.2021.08.012.
       Full Text  Open Access Copy  Link to Item
    • Mayne, Nicholas R., Alice J. Darling, Vignesh Raman, Scott Balderson, Mark F. Berry, David H. Harpole, Thomas A. D’Amico, and Chi-Fu Jeffrey Yang. “Perioperative Outcomes and 5-year Survival After Open versus Thoracoscopic Sleeve Resection for Lung Cancer.” Seminars in Thoracic and Cardiovascular Surgery 33, no. 2 (June 2021): 522–30. https://doi.org/10.1053/j.semtcvs.2020.08.013.
       Full Text
    • Tong, Betty C., Lin Gu, Xiaofei Wang, Dennis A. Wigle, Joseph D. Phillips, David H. Harpole, Jacob A. Klapper, Thomas Sporn, Neal E. Ready, and Thomas A. D’Amico. “Perioperative outcomes of pulmonary resection after neoadjuvant pembrolizumab in patients with non-small cell lung cancer.” J Thorac Cardiovasc Surg, April 9, 2021. https://doi.org/10.1016/j.jtcvs.2021.02.099.
       Full Text  Link to Item
    • Farrow, Norma E., Vignesh Raman, Oliver K. Jawitz, Soraya L. Voigt, Betty C. Tong, David H. Harpole, and Thomas A. D’Amico. “Impact of Age on Surgical Outcomes for Locally Advanced Esophageal Cancer.” Ann Thorac Surg 111, no. 3 (March 2021): 996–1003. https://doi.org/10.1016/j.athoracsur.2020.06.055.
       Full Text  Link to Item
    • Terrando, Niccolò, John J. Park, Michael Devinney, Cliburn Chan, Mary Cooter, Pallavi Avasarala, Joseph P. Mathew, et al. “Immunomodulatory lipid mediator profiling of cerebrospinal fluid following surgery in older adults.” Sci Rep 11, no. 1 (February 4, 2021): 3047. https://doi.org/10.1038/s41598-021-82606-5.
       Full Text  Link to Item
    • Rhodin, Kristen E., Vignesh Raman, Oliver K. Jawitz, Soraya L. Voigt, Norma E. Farrow, David H. Harpole, Betty C. Tong, and Thomas A. D’Amico. “Patterns of Use of Induction Therapy for T2N0 Esophageal Cancer.” Ann Thorac Surg 111, no. 2 (February 2021): 440–47. https://doi.org/10.1016/j.athoracsur.2020.05.089.
       Full Text  Link to Item
    • Raman, Vignesh, Oliver K. Jawitz, Soraya L. Voigt, Kristen E. Rhodin, Thomas A. D’Amico, David H. Harpole, Chi-Fu Jeffrey Yang, and Betty C. Tong. “The Effect of Tumor Size and Histologic Findings on Outcomes After Segmentectomy vs Lobectomy for Clinically Node-Negative Non-Small Cell Lung Cancer.” Chest 159, no. 1 (January 2021): 390–400. https://doi.org/10.1016/j.chest.2020.06.066.
       Full Text  Link to Item
    • VanDusen, Keith W., Yi-Ju Li, Victor Cai, Ashley Hall, Sarah Hiles, J Will Thompson, M Arthur Moseley, et al. “Cerebrospinal Fluid Proteome Changes in Older Non-Cardiac Surgical Patients with Postoperative Cognitive Dysfunction.” J Alzheimers Dis 80, no. 3 (2021): 1281–97. https://doi.org/10.3233/JAD-201544.
       Full Text  Open Access Copy  Link to Item
    • Raman, Vignesh, Oliver K. Jawitz, Soraya L. Voigt, Kristen E. Rhodin, Anthony W. Kim, Betty C. Tong, Thomas A. D’Amico, and David H. Harpole. “Patterns of Care in Neoadjuvant Chemoradiotherapy for Node-Positive Esophageal Adenocarcinoma.” Ann Thorac Surg 110, no. 6 (December 2020): 1832–39. https://doi.org/10.1016/j.athoracsur.2020.05.069.
       Full Text  Link to Item
    • Rucker, A Justin, Vignesh Raman, Oliver K. Jawitz, Soraya L. Voigt, Betty C. Tong, Thomas A. D’Amico, and David H. Harpole. “Effect of Lymph Node Assessment on Outcomes in Surgery for Limited Stage Small Cell Lung Cancer.” Ann Thorac Surg 110, no. 6 (December 2020): 1854–60. https://doi.org/10.1016/j.athoracsur.2020.04.117.
       Full Text  Link to Item
    • Bueno, Raphael, William G. Richards, David H. Harpole, Karla V. Ballman, Ming-Sound Tsao, Zhengming Chen, Xiaofei Wang, et al. “Multi-Institutional Prospective Validation of Prognostic mRNA Signatures in Early Stage Squamous Lung Cancer (Alliance).” J Thorac Oncol 15, no. 11 (November 2020): 1748–57. https://doi.org/10.1016/j.jtho.2020.07.005.
       Full Text  Link to Item
    • Voigt, Soraya L., Vignesh Raman, Oliver K. Jawitz, Muath Bishawi, Chi-Fu Jeffrey Yang, Betty C. Tong, Thomas A. D’Amico, and David H. Harpole. “The Role of Neoadjuvant Chemotherapy in Patients With Resectable Malignant Pleural Mesothelioma-An Institutional and National Analysis.” Journal of the National Cancer Institute 112, no. 11 (November 2020): 1118–27. https://doi.org/10.1093/jnci/djaa002.
       Full Text
    • Ganesh, Arun, Yawar J. Qadri, Richard L. Boortz-Marx, Sana M. Al-Khatib, David H. Harpole, Jason N. Katz, Jason I. Koontz, et al. “Stellate Ganglion Blockade: an Intervention for the Management of Ventricular Arrhythmias.” Curr Hypertens Rep 22, no. 12 (October 23, 2020): 100. https://doi.org/10.1007/s11906-020-01111-8.
       Full Text  Open Access Copy  Link to Item
    • Rhodin, Kristen E., Vignesh Raman, Oliver K. Jawitz, Betty C. Tong, David H. Harpole, and Thomas A. D’Amico. “The Effect of Timing of Adjuvant Therapy on Survival After Esophagectomy.” Ann Thorac Surg 110, no. 3 (September 2020): 1023–29. https://doi.org/10.1016/j.athoracsur.2020.03.040.
       Full Text  Link to Item
    • Nobuhara, Chloe K., W Michael Bullock, Thomas Bunning, Brian Colin, Mary Cooter, Michael J. Devinney, Michael N. Ferrandino, et al. “A protocol to reduce self-reported pain scores and adverse events following lumbar punctures in older adults.” J Neurol 267, no. 7 (July 2020): 2002–6. https://doi.org/10.1007/s00415-020-09797-1.
       Full Text  Link to Item
    • Fudim, Marat, Yawar J. Qadri, Nathan H. Waldron, Richard L. Boortz-Marx, Arun Ganesh, Chetan B. Patel, Mihai V. Podgoreanu, et al. “Stellate Ganglion Blockade for the Treatment of Refractory Ventricular Arrhythmias.” Jacc Clin Electrophysiol 6, no. 5 (May 2020): 562–71. https://doi.org/10.1016/j.jacep.2019.12.017.
       Full Text  Link to Item
    • Raman, Vignesh, Oliver K. Jawitz, Chi-Fu J. Yang, Soraya L. Voigt, Anthony W. Kim, Betty C. Tong, Thomas A. D’Amico, and David H. Harpole. “The influence of adjuvant therapy on survival in patients with indeterminate margins following surgery for non-small cell lung cancer.” The Journal of Thoracic and Cardiovascular Surgery 159, no. 5 (May 2020): 2030-2040.e4. https://doi.org/10.1016/j.jtcvs.2019.09.075.
       Full Text
    • Raman, Vignesh, Oliver K. Jawitz, Soraya L. Voigt, Chi-Fu J. Yang, Thomas A. D’Amico, and David H. Harpole. “The Role of Adjuvant Therapy in Patients With Margin-Positive (R1) Esophagectomy: A National Analysis.” The Journal of Surgical Research 249 (May 2020): 82–90. https://doi.org/10.1016/j.jss.2019.11.035.
       Full Text
    • Raman, Vignesh, Oliver K. Jawitz, Soraya L. Voigt, Chi-Fu J. Yang, Hanghang Wang, David H. Harpole, and Thomas A. D’Amico. “Effect of time to surgery on outcomes in stage I esophageal adenocarcinoma.” J Thorac Cardiovasc Surg 159, no. 4 (April 2020): 1626-1635.e1. https://doi.org/10.1016/j.jtcvs.2019.09.123.
       Full Text  Link to Item
    • Rucker, A Justin, Vignesh Raman, Oliver K. Jawitz, Soraya L. Voigt, David H. Harpole, Thomas A. D’Amico, and Betty C. Tong. “The Impact of Adjuvant Therapy on Survival After Esophagectomy for Node-negative Esophageal Adenocarcinoma.” Ann Surg, March 20, 2020. https://doi.org/10.1097/SLA.0000000000003886.
       Full Text  Link to Item
    • Raman, Vignesh, Oliver K. Jawitz, Chi-Fu J. Yang, Soraya L. Voigt, Betty C. Tong, Thomas A. D’Amico, and David H. Harpole. “Outcomes for Surgery in Large Cell Lung Neuroendocrine Cancer.” J Thorac Oncol 14, no. 12 (December 2019): 2143–51. https://doi.org/10.1016/j.jtho.2019.09.005.
       Full Text  Link to Item
    • Raman, Vignesh, Oliver K. Jawitz, Chi-Fu J. Yang, Soraya L. Voigt, Hanghang Wang, Thomas A. D’Amico, David H. Harpole, and Betty C. Tong. “Outcomes of surgery versus chemoradiotherapy in patients with clinical or pathologic stage N3 non-small cell lung cancer.” J Thorac Cardiovasc Surg 158, no. 6 (December 2019): 1680-1692.e2. https://doi.org/10.1016/j.jtcvs.2019.08.033.
       Full Text  Link to Item
    • Raman, Vignesh, Oliver K. Jawitz, Soraya L. Voigt, Norma E. Farrow, Chi-Fu J. Yang, Thomas A. D’Amico, and David H. Harpole. “Surgery Is Associated With Survival Benefit in T4a Esophageal Adenocarcinoma: A National Analysis.” Ann Thorac Surg 108, no. 6 (December 2019): 1633–39. https://doi.org/10.1016/j.athoracsur.2019.05.091.
       Full Text  Link to Item
    • Berger, Miles, David M. Murdoch, Janet S. Staats, Cliburn Chan, Jake P. Thomas, Grant E. Garrigues, Jeffrey N. Browndyke, et al. “Flow Cytometry Characterization of Cerebrospinal Fluid Monocytes in Patients With Postoperative Cognitive Dysfunction: A Pilot Study.” Anesth Analg 129, no. 5 (November 2019): e150–54. https://doi.org/10.1213/ANE.0000000000004179.
       Full Text  Open Access Copy  Link to Item
    • Tsao, Ming-Sound, Michele Carbone, Francoise Galateau-Salle, Andre L. Moreira, Andrew G. Nicholson, Anja C. Roden, Alex A. Adjei, et al. “Pathologic Considerations and Standardization in Mesothelioma Clinical Trials.” J Thorac Oncol 14, no. 10 (October 2019): 1704–17. https://doi.org/10.1016/j.jtho.2019.06.020.
       Full Text  Link to Item
    • Gill, Ritu R., Anne S. Tsao, Hedy L. Kindler, William G. Richards, Samuel G. Armato, Roslyn J. Francis, Daniel R. Gomez, et al. “Radiologic Considerations and Standardization of Malignant Pleural Mesothelioma Imaging Within Clinical Trials: Consensus Statement from the NCI Thoracic Malignancy Steering Committee - International Association for the Study of Lung Cancer - Mesothelioma Applied Research Foundation Clinical Trials Planning Meeting.” Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer 14, no. 10 (October 2019): 1718–31. https://doi.org/10.1016/j.jtho.2019.08.012.
       Full Text
    • Friedberg, Joseph S., Melissa J. Culligan, Anne S. Tsao, Valerie Rusch, Boris Sepesi, Harvey I. Pass, Raphael Bueno, et al. “A Proposed System Toward Standardizing Surgical-Based Treatments for Malignant Pleural Mesothelioma, From the Joint National Cancer Institute-International Association for the Study of Lung Cancer-Mesothelioma Applied Research Foundation Taskforce.” J Thorac Oncol 14, no. 8 (August 2019): 1343–53. https://doi.org/10.1016/j.jtho.2019.04.029.
       Full Text  Link to Item
    • Raman, Vignesh, Oliver K. Jawitz, Chi-Fu J. Yang, Betty C. Tong, Thomas A. D’Amico, Mark F. Berry, and David H. Harpole. “Adjuvant Therapy for Patients With Early Large Cell Lung Neuroendocrine Cancer: A National Analysis.” Ann Thorac Surg 108, no. 2 (August 2019): 377–83. https://doi.org/10.1016/j.athoracsur.2019.03.053.
       Full Text  Link to Item
    • Gomez, Daniel R., Andreas Rimner, Charles B. Simone, BC John Cho, Marc de Perrot, Alex A. Adjei, Raphael Bueno, et al. “The Use of Radiation Therapy for the Treatment of Malignant Pleural Mesothelioma: Expert Opinion from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation.” J Thorac Oncol 14, no. 7 (July 2019): 1172–83. https://doi.org/10.1016/j.jtho.2019.03.030.
       Full Text  Link to Item
    • Klinger, Rebecca Y., Mary Cooter, Tiffany Bisanar, Niccolò Terrando, Miles Berger, Mihai V. Podgoreanu, Mark Stafford-Smith, Mark F. Newman, Joseph P. Mathew, and Joseph P. Neurologic Outcomes Research Group of the Duke Heart Center. “Intravenous Lidocaine Does Not Improve Neurologic Outcomes after Cardiac Surgery: A Randomized Controlled Trial.” Anesthesiology 130, no. 6 (June 2019): 958–70. https://doi.org/10.1097/ALN.0000000000002668.
       Full Text  Link to Item
    • Berger, Miles, Deborah Oyeyemi, Mobolaji O. Olurinde, Heather E. Whitson, Kent J. Weinhold, Marty G. Woldorff, Lewis A. Lipsitz, et al. “The INTUIT Study: Investigating Neuroinflammation Underlying Postoperative Cognitive Dysfunction.” J Am Geriatr Soc 67, no. 4 (April 2019): 794–98. https://doi.org/10.1111/jgs.15770.
       Full Text  Open Access Copy  Link to Item
    • Barac, Yaron D., David Harold Harpole, Kamrouz Ghadimi, and Carmelo A. Milano. “A One-Step Autotransplantation Can Facilitate the Excision of Cardiac Tumors Invading the Lung.” Semin Thorac Cardiovasc Surg 31, no. 3 (2019): 475–76. https://doi.org/10.1053/j.semtcvs.2019.01.012.
       Full Text  Link to Item
    • Yu, Hui, Zhengming Chen, Karla V. Ballman, Mark A. Watson, Ramaswamy Govindan, Irena Lanc, David G. Beer, et al. “Correlation of PD-L1 Expression with Tumor Mutation Burden and Gene Signatures for Prognosis in Early-Stage Squamous Cell Lung Carcinoma.” J Thorac Oncol 14, no. 1 (January 2019): 25–36. https://doi.org/10.1016/j.jtho.2018.09.006.
       Full Text  Link to Item
    • Yang, Chi-Fu Jeffrey, Arvind Kumar, Jacob A. Klapper, Matthew G. Hartwig, Betty C. Tong, David H. Harpole, Mark F. Berry, and Thomas A. D’Amico. “A National Analysis of Long-term Survival Following Thoracoscopic Versus Open Lobectomy for Stage I Non-small-cell Lung Cancer.” Annals of Surgery 269, no. 1 (January 2019): 163–71. https://doi.org/10.1097/sla.0000000000002342.
       Full Text
    • Crowson, Matthew G., Betty C. Tong, Hui-Jie Lee, Yao Song, David H. Harpole, Harrison N. Jones, and Seth Cohen. “Prevalence and resource utilization for vocal fold paralysis/paresis after esophagectomy.” Laryngoscope 128, no. 12 (December 2018): 2815–22. https://doi.org/10.1002/lary.27252.
       Full Text  Link to Item
    • Yang, Chi-Fu Jeffrey, Derek Y. Chan, Shivani A. Shah, Babatunde A. Yerokun, Xiaofei F. Wang, Thomas A. D’Amico, Mark F. Berry, and David H. Harpole. “Long-term Survival After Surgery Compared With Concurrent Chemoradiation for Node-negative Small Cell Lung Cancer.” Ann Surg 268, no. 6 (December 2018): 1105–12. https://doi.org/10.1097/SLA.0000000000002287.
       Full Text  Link to Item
    • Tsao, Anne S., O Wolf Lindwasser, Alex A. Adjei, Prasad S. Adusumilli, Matthew L. Beyers, Gideon M. Blumenthal, Raphael Bueno, et al. “Current and Future Management of Malignant Mesothelioma: A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation.” J Thorac Oncol 13, no. 11 (November 2018): 1655–67. https://doi.org/10.1016/j.jtho.2018.08.2036.
       Full Text  Link to Item
    • Hodapp, Dorothee, Elizabeth T. Borer, W Stanley Harpole, Eric M. Lind, Eric W. Seabloom, Peter B. Adler, Juan Alberti, et al. “Spatial heterogeneity in species composition constrains plant community responses to herbivory and fertilisation.” Ecol Lett 21, no. 9 (September 2018): 1364–71. https://doi.org/10.1111/ele.13102.
       Full Text  Link to Item
    • Yang, Chi-Fu Jeffrey, Kelli Aibel, Ryan Meyerhoff, Frances Wang, David Harpole, Amy P. Abernethy, and Thomas W. LeBlanc. “Actigraphy assessment of sleep quality among patients with acute myeloid leukaemia during induction chemotherapy.” Bmj Support Palliat Care 8, no. 3 (September 2018): 274–77. https://doi.org/10.1136/bmjspcare-2018-001509.
       Full Text  Link to Item
    • Anderson, T Michael, Daniel M. Griffith, James B. Grace, Eric M. Lind, Peter B. Adler, Lori A. Biederman, Dana M. Blumenthal, et al. “Herbivory and eutrophication mediate grassland plant nutrient responses across a global climatic gradient.” Ecology 99, no. 4 (April 2018): 822–31. https://doi.org/10.1002/ecy.2175.
       Full Text  Link to Item
    • Frater, P. N., E. T. Borer, P. A. Fay, V. Jin, B. Knaeble, E. Seabloom, L. Sullivan, D. A. Wedin, and W. S. Harpole. “Nutrients and environment influence arbuscular mycorrhizal colonization both independently and interactively in Schizachyrium scoparium.” Plant and Soil 425, no. 1–2 (April 1, 2018): 493–506. https://doi.org/10.1007/s11104-018-3597-6.
       Full Text
    • Moris, Dimitrios, Ioannis Ntanasis-Stathopoulos, Diamantis I. Tsilimigras, Mohamad A. Adam, Chi-Fu Jeffrey Yang, David Harpole, and Stamatios Theocharis. “Insights into Novel Prognostic and Possible Predictive Biomarkers of Lung Neuroendocrine Tumors.” Cancer Genomics Proteomics 15, no. 2 (March 2018): 153–63. https://doi.org/10.21873/cgp.20073.
       Full Text  Link to Item
    • Yang, Chi-Fu Jeffrey, Frances McSherry, Nicholas R. Mayne, Xiaofei Wang, Mark F. Berry, Betty Tong, David H. Harpole, et al. “Surgical Outcomes After Neoadjuvant Chemotherapy and Ipilimumab for Non-Small Cell Lung Cancer.” Ann Thorac Surg 105, no. 3 (March 2018): 924–29. https://doi.org/10.1016/j.athoracsur.2017.09.030.
       Full Text  Link to Item
    • Hillebrand, H., B. Blasius, E. T. Borer, J. M. Chase, J. A. Downing, B. K. Eriksson, C. T. Filstrup, et al. “Biodiversity change is uncoupled from species richness trends: Consequences for conservation and monitoring.” Journal of Applied Ecology 55, no. 1 (January 1, 2018): 169–84. https://doi.org/10.1111/1365-2664.12959.
       Full Text
    • Mortensen, B., B. Danielson, W. S. Harpole, J. Alberti, C. A. Arnillas, L. Biederman, E. T. Borer, et al. “Herbivores safeguard plant diversity by reducing variability in dominance.” Journal of Ecology 106, no. 1 (January 1, 2018): 101–12. https://doi.org/10.1111/1365-2745.12821.
       Full Text
    • Hautier, Yann, Forest Isbell, Elizabeth T. Borer, Eric W. Seabloom, W Stanley Harpole, Eric M. Lind, Andrew S. MacDougall, et al. “Local loss and spatial homogenization of plant diversity reduce ecosystem multifunctionality.” Nat Ecol Evol 2, no. 1 (January 2018): 50–56. https://doi.org/10.1038/s41559-017-0395-0.
       Full Text  Link to Item
    • Yi, John S., Neal Ready, Patrick Healy, Chelsae Dumbauld, Robyn Osborne, Mark Berry, Debra Shoemaker, et al. “Immune Activation in Early-Stage Non-Small Cell Lung Cancer Patients Receiving Neoadjuvant Chemotherapy Plus Ipilimumab.” Clin Cancer Res 23, no. 24 (December 15, 2017): 7474–82. https://doi.org/10.1158/1078-0432.CCR-17-2005.
       Full Text  Link to Item
    • Boyer, Matthew J., Christina D. Williams, David H. Harpole, Mark W. Onaitis, Michael J. Kelley, and Joseph K. Salama. “Improved Survival of Stage I Non-Small Cell Lung Cancer: A VA Central Cancer Registry Analysis.” J Thorac Oncol 12, no. 12 (December 2017): 1814–23. https://doi.org/10.1016/j.jtho.2017.09.1952.
       Full Text  Link to Item
    • Anderson, Kevin L., Michael S. Mulvihill, Paul J. Speicher, Babatunde A. Yerokun, Brian C. Gulack, Daniel P. Nussbaum, David H. Harpole, Thomas A. D’Amico, Mark F. Berry, and Matthew G. Hartwig. “Adjuvant Chemotherapy Does Not Confer Superior Survival in Patients With Atypical Carcinoid Tumors.” Ann Thorac Surg 104, no. 4 (October 2017): 1221–30. https://doi.org/10.1016/j.athoracsur.2017.05.011.
       Full Text  Link to Item
    • Harpole, W. S., L. L. Sullivan, E. M. Lind, J. Firn, P. B. Adler, E. T. Borer, J. Chase, et al. “Out of the shadows: multiple nutrient limitations drive relationships among biomass, light and plant diversity.” Functional Ecology 31, no. 9 (September 1, 2017): 1839–46. https://doi.org/10.1111/1365-2435.12967.
       Full Text
    • Yerokun, Babatunde A., Chi-Fu Jeffrey Yang, Brian C. Gulack, Xuechan Li, Michael S. Mulvihill, Lin Gu, Xiaofei Wang, et al. “A national analysis of wedge resection versus stereotactic body radiation therapy for stage IA non-small cell lung cancer.” J Thorac Cardiovasc Surg 154, no. 2 (August 2017): 675-686.e4. https://doi.org/10.1016/j.jtcvs.2017.02.065.
       Full Text  Link to Item
    • Yao, Xiaoxin I., Xiaofei Wang, Paul J. Speicher, E Shelley Hwang, Perry Cheng, David H. Harpole, Mark F. Berry, Deborah Schrag, and Herbert H. Pang. “Reporting and Guidelines in Propensity Score Analysis: A Systematic Review of Cancer and Cancer Surgical Studies.” J Natl Cancer Inst 109, no. 8 (August 1, 2017). https://doi.org/10.1093/jnci/djw323.
       Full Text  Link to Item
    • Yang, Chi-Fu Jeffrey, Derek Y. Chan, Paul J. Speicher, Brian C. Gulack, Betty C. Tong, Matthew G. Hartwig, Christopher R. Kelsey, Thomas A. D’Amico, Mark F. Berry, and David H. Harpole. “Surgery Versus Optimal Medical Management for N1 Small Cell Lung Cancer.” Ann Thorac Surg 103, no. 6 (June 2017): 1767–72. https://doi.org/10.1016/j.athoracsur.2017.01.043.
       Full Text  Link to Item
    • “Discussion.” J Thorac Cardiovasc Surg 153, no. 6 (June 2017): 1576–78. https://doi.org/10.1016/j.jtcvs.2016.12.065.
       Full Text  Link to Item
    • Borer, Elizabeth T., James B. Grace, W Stanley Harpole, Andrew S. MacDougall, and Eric W. Seabloom. “A decade of insights into grassland ecosystem responses to global environmental change.” Nat Ecol Evol 1, no. 5 (April 20, 2017): 118. https://doi.org/10.1038/s41559-017-0118.
       Full Text  Link to Item
    • Cox, Morgan L., Chi-Fu Jeffrey Yang, Paul J. Speicher, Kevin L. Anderson, Zachary W. Fitch, Lin Gu, Robert Patrick Davis, et al. “The Role of Extent of Surgical Resection and Lymph Node Assessment for Clinical Stage I Pulmonary Lepidic Adenocarcinoma: An Analysis of 1991 Patients.” J Thorac Oncol 12, no. 4 (April 2017): 689–96. https://doi.org/10.1016/j.jtho.2017.01.003.
       Full Text  Link to Item
    • Yang, Chi-Fu Jeffrey, Derek Y. Chan, Thomas A. D’Amico, Mark F. Berry, and David H. Harpole. “Reply to D.A. Palma.” J Clin Oncol 35, no. 5 (February 10, 2017): 572. https://doi.org/10.1200/JCO.2016.70.2787.
       Full Text  Link to Item
    • Giattino, Charles M., Jacob E. Gardner, Faris M. Sbahi, Kenneth C. Roberts, Mary Cooter, Eugene Moretti, Jeffrey N. Browndyke, et al. “Intraoperative Frontal Alpha-Band Power Correlates with Preoperative Neurocognitive Function in Older Adults.” Front Syst Neurosci 11 (2017): 24. https://doi.org/10.3389/fnsys.2017.00024.
       Full Text  Open Access Copy  Link to Item
    • Torok, Jordan A., Lin Gu, Daniel J. Tandberg, Xiaofei Wang, David H. Harpole, Chris R. Kelsey, and Joseph K. Salama. “Patterns of Distant Metastases After Surgical Management of Non-Small-cell Lung Cancer.” Clin Lung Cancer 18, no. 1 (January 2017): e57–70. https://doi.org/10.1016/j.cllc.2016.06.011.
       Full Text  Link to Item
    • Yang, Chi-Fu Jeffrey, Derek Y. Chan, Xiaofei Wang, Thomas A. D’Amico, David H. Harpole, and Mark F. Berry. “Reply to T.-H. Wang et al.” J Clin Oncol 35, no. 1 (January 2017): 118–20. https://doi.org/10.1200/JCO.2016.68.6980.
       Full Text  Link to Item
    • Gulack, Brian C., Chi-Fu Jeffrey Yang, Paul J. Speicher, Babatunde A. Yerokun, Betty C. Tong, Mark W. Onaitis, Thomas A. D’Amico, David H. Harpole, Matthew G. Hartwig, and Mark F. Berry. “A Risk Score to Assist Selecting Lobectomy Versus Sublobar Resection for Early Stage Non-Small Cell Lung Cancer.” Ann Thorac Surg 102, no. 6 (December 2016): 1814–20. https://doi.org/10.1016/j.athoracsur.2016.06.032.
       Full Text  Link to Item
    • Speicher, Paul J., Zachary W. Fitch, Brian C. Gulack, Chi-Fu J. Yang, Betty C. Tong, David H. Harpole, Thomas A. D’Amico, Mark F. Berry, and Matthew G. Hartwig. “Induction Chemotherapy is Not Superior to a Surgery-First Strategy for Clinical N1 Non-Small Cell Lung Cancer.” Ann Thorac Surg 102, no. 3 (September 2016): 884–94. https://doi.org/10.1016/j.athoracsur.2016.05.065.
       Full Text  Link to Item
    • Yang, Chi-Fu Jeffrey, Brandon W. Yan, Robert Ryan Meyerhoff, Shakir M. Saud, Brian C. Gulack, Paul J. Speicher, Matthew G. Hartwig, Thomas A. D’Amico, David H. Harpole, and Mark F. Berry. “Impact of Age on Long-Term Outcomes of Surgery for Malignant Pleural Mesothelioma.” Clin Lung Cancer 17, no. 5 (September 2016): 419–26. https://doi.org/10.1016/j.cllc.2016.03.002.
       Full Text  Link to Item
    • Yang, Chi-Fu Jeffrey, Nicholas R. Mayne, Hanghang Wang, Ryan R. Meyerhoff, Sameer Hirji, Betty C. Tong, Matthew Hartwig, David Harpole, Thomas A. D’Amico, and Mark Berry. “Outcomes of Major Lung Resection After Induction Therapy for Non-Small Cell Lung Cancer in Elderly Patients.” Ann Thorac Surg 102, no. 3 (September 2016): 962–70. https://doi.org/10.1016/j.athoracsur.2016.03.088.
       Full Text  Link to Item
    • Yerokun, Babatunde A., Zhifei Sun, Chi-Fu Jeffrey Yang, Brian C. Gulack, Paul J. Speicher, Mohamed A. Adam, Thomas A. D’Amico, et al. “Minimally Invasive Versus Open Esophagectomy for Esophageal Cancer: A Population-Based Analysis.” Ann Thorac Surg 102, no. 2 (August 2016): 416–23. https://doi.org/10.1016/j.athoracsur.2016.02.078.
       Full Text  Link to Item
    • Yang, Chi-Fu Jeffrey, Robert Ryan Meyerhoff, Nicholas Ryan Mayne, Terry Singhapricha, Christopher B. Toomey, Paul J. Speicher, Matthew G. Hartwig, et al. “Long-term survival following open versus thoracoscopic lobectomy after preoperative chemotherapy for non-small cell lung cancer.” Eur J Cardiothorac Surg 49, no. 6 (June 2016): 1615–23. https://doi.org/10.1093/ejcts/ezv428.
       Full Text  Link to Item
    • Yang, Chi-Fu Jeffrey, Syed M. Adil, Kevin L. Anderson, Robert Ryan Meyerhoff, Ryan S. Turley, Matthew G. Hartwig, David H. Harpole, et al. “Impact of patient selection and treatment strategies on outcomes after lobectomy for biopsy-proven stage IIIA pN2 non-small cell lung cancer.” Eur J Cardiothorac Surg 49, no. 6 (June 2016): 1607–13. https://doi.org/10.1093/ejcts/ezv431.
       Full Text  Link to Item
    • Yang, Chi-Fu Jeffrey, Derek Y. Chan, Paul J. Speicher, Brian C. Gulack, Xiaofei Wang, Matthew G. Hartwig, Mark W. Onaitis, et al. “Role of Adjuvant Therapy in a Population-Based Cohort of Patients With Early-Stage Small-Cell Lung Cancer.” J Clin Oncol 34, no. 10 (April 1, 2016): 1057–64. https://doi.org/10.1200/JCO.2015.63.8171.
       Full Text  Link to Item
    • Yang, Chi-Fu Jeffrey, Zhifei Sun, Paul J. Speicher, Shakir M. Saud, Brian C. Gulack, Matthew G. Hartwig, David H. Harpole, et al. “Use and Outcomes of Minimally Invasive Lobectomy for Stage I Non-Small Cell Lung Cancer in the National Cancer Data Base.” Ann Thorac Surg 101, no. 3 (March 2016): 1037–42. https://doi.org/10.1016/j.athoracsur.2015.11.018.
       Full Text  Link to Item
    • Scott, Christopher D., and David H. Harpole. “The Biology of Pulmonary Metastasis.” Thorac Surg Clin 26, no. 1 (February 2016): 1–6. https://doi.org/10.1016/j.thorsurg.2015.09.001.
       Full Text  Link to Item
    • Harpole, David H. “The Integrated Comprehensive Care Program: A Novel Home Care Initiative After Major Thoracic Surgery.” Semin Thorac Cardiovasc Surg 28, no. 2 (2016): 582–84. https://doi.org/10.1053/j.semtcvs.2016.05.005.
       Full Text  Link to Item
    • Yang, Chi-Fu Jeffrey, Brian C. Gulack, Lin Gu, Paul J. Speicher, Xiaofei Wang, David H. Harpole, Mark W. Onaitis, Thomas A. D’Amico, Mark F. Berry, and Matthew G. Hartwig. “Adding radiation to induction chemotherapy does not improve survival of patients with operable clinical N2 non-small cell lung cancer.” J Thorac Cardiovasc Surg 150, no. 6 (December 2015): 1484–92. https://doi.org/10.1016/j.jtcvs.2015.06.062.
       Full Text  Link to Item
    • Saunders, Laura R., Alexander J. Bankovich, Wade C. Anderson, Monette A. Aujay, Sheila Bheddah, KristenAnn Black, Radhika Desai, et al. “A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo.” Sci Transl Med 7, no. 302 (August 26, 2015): 302ra136. https://doi.org/10.1126/scitranslmed.aac9459.
       Full Text  Link to Item
    • Berry, Mark F., Chi-Fu Jeffrey Yang, Matthew G. Hartwig, Betty C. Tong, David H. Harpole, Thomas A. D’Amico, and Mark W. Onaitis. “Impact of Pulmonary Function Measurements on Long-Term Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer.” Ann Thorac Surg 100, no. 1 (July 2015): 271–76. https://doi.org/10.1016/j.athoracsur.2015.02.076.
       Full Text  Link to Item
    • Yang, Chi-Fu Jeffrey, R Ryan Meyerhoff, Sarah J. Stephens, Terry Singhapricha, Christopher B. Toomey, Kevin L. Anderson, Chris Kelsey, David Harpole, Thomas A. D’Amico, and Mark F. Berry. “Long-Term Outcomes of Lobectomy for Non-Small Cell Lung Cancer After Definitive Radiation Treatment.” Ann Thorac Surg 99, no. 6 (June 2015): 1914–20. https://doi.org/10.1016/j.athoracsur.2015.01.064.
       Full Text  Link to Item
    • Little, Alex G., Antoon E. Lerut, David H. Harpole, Wayne L. Hofstetter, John D. Mitchell, Nasser K. Altorki, and Mark J. Krasna. “The Society of Thoracic Surgeons practice guidelines on the role of multimodality treatment for cancer of the esophagus and gastroesophageal junction.” Ann Thorac Surg 98, no. 5 (November 2014): 1880–85. https://doi.org/10.1016/j.athoracsur.2014.07.069.
       Full Text  Link to Item
    • Malik, Shakun M., Richard Pazdur, Jeffrey S. Abrams, Mark A. Socinski, William T. Sause, David H. Harpole, John J. Welch, Edward L. Korn, Claudio Dansky Ullmann, and Fred R. Hirsch. “Consensus report of a joint NCI thoracic malignancies steering committee: FDA workshop on strategies for integrating biomarkers into clinical development of new therapies for lung cancer leading to the inception of "master protocols" in lung cancer.” J Thorac Oncol 9, no. 10 (October 2014): 1443–48. https://doi.org/10.1097/JTO.0000000000000314.
       Full Text  Link to Item
    • Harpole, W. S., and L. A. Biederman. “On the importance of accurate reporting: A response to comments on 'Biochar and its effects on plant productivity and nutrient cycling: A meta-analysis'.” Gcb Bioenergy 6, no. 3 (January 1, 2014): 172–75. https://doi.org/10.1111/gcbb.12093.
       Full Text
    • Jaklitsch, Michael T., Lin Gu, Todd Demmy, David H. Harpole, Thomas A. D’Amico, Robert J. McKenna, Mark J. Krasna, et al. “Prospective phase II trial of preresection thoracoscopic mediastinal restaging after neoadjuvant therapy for IIIA (N2) non-small cell lung cancer: results of CALGB Protocol 39803.” J Thorac Cardiovasc Surg 146, no. 1 (July 2013): 9–16. https://doi.org/10.1016/j.jtcvs.2012.12.069.
       Full Text  Link to Item
    • Erhunmwunsee, Loretta, Mary-Beth M. Joshi, Debbi H. Conlon, and David H. Harpole. “Neighborhood-level socioeconomic determinants impact outcomes in nonsmall cell lung cancer patients in the Southeastern United States.” Cancer 118, no. 20 (October 15, 2012): 5117–23. https://doi.org/10.1002/cncr.26185.
       Full Text  Link to Item
    • Cuneo, Kyle C., Richard F. Riedel, Leslie G. Dodd, David H. Harpole, and David G. Kirsch. “Pathologic complete response of a malignant peripheral nerve sheath tumor in the lung treated with neoadjuvant Ifosfamide and radiation therapy.” J Clin Oncol 30, no. 28 (October 1, 2012): e291–93. https://doi.org/10.1200/JCO.2012.42.8797.
       Full Text  Link to Item
    • Ceppa, DuyKhanh P., Andrzej S. Kosinski, Mark F. Berry, Betty C. Tong, David H. Harpole, John D. Mitchell, Thomas A. D’Amico, and Mark W. Onaitis. “Thoracoscopic lobectomy has increasing benefit in patients with poor pulmonary function: a Society of Thoracic Surgeons Database analysis.” Ann Surg 256, no. 3 (September 2012): 487–93. https://doi.org/10.1097/SLA.0b013e318265819c.
       Full Text  Link to Item
    • Patel, Pretesh R., Sua Yoo, Gloria Broadwater, Lawrence B. Marks, Edward F. Miles, Thomas A. D’Amico, David Harpole, and Chris R. Kelsey. “Effect of increasing experience on dosimetric and clinical outcomes in the management of malignant pleural mesothelioma with intensity-modulated radiation therapy.” Int J Radiat Oncol Biol Phys 83, no. 1 (May 1, 2012): 362–68. https://doi.org/10.1016/j.ijrobp.2011.11.057.
       Full Text  Link to Item
    • Berry, Mark F., Mark W. Onaitis, Betty C. Tong, Stafford S. Balderson, David H. Harpole, and Thomas A. D’Amico. “Feasibility of hybrid thoracoscopic lobectomy and en-bloc chest wall resection.” Eur J Cardiothorac Surg 41, no. 4 (April 2012): 888–92. https://doi.org/10.1093/ejcts/ezr150.
       Full Text  Link to Item
    • Shah, Asad A., Michael E. Barfield, Chris R. Kelsey, Mark W. Onaitis, Betty Tong, David Harpole, Thomas A. D’Amico, and Mark F. Berry. “Outcomes after surgical management of synchronous bilateral primary lung cancers.” Ann Thorac Surg 93, no. 4 (April 2012): 1055–60. https://doi.org/10.1016/j.athoracsur.2011.12.070.
       Full Text  Link to Item
    • Tong, Betty C., and David H. Harpole. “Molecular markers for incidence, prognosis, and response to therapy.” Surg Oncol Clin N Am 21, no. 1 (January 2012): 161–75. https://doi.org/10.1016/j.soc.2011.09.007.
       Full Text  Link to Item
    • Ceppa, Duykhanh P., Ian J. Welsby, Tracy Y. Wang, Mark W. Onaitis, Betty C. Tong, David H. Harpole, Thomas A. D’Amico, and Mark F. Berry. “Perioperative management of patients on clopidogrel (Plavix) undergoing major lung resection.” Ann Thorac Surg 92, no. 6 (December 2011): 1971–76. https://doi.org/10.1016/j.athoracsur.2011.07.052.
       Full Text  Link to Item
    • D’Alonzo, Richard C., Elliott Bennett-Guerrero, Mihai Podgoreanu, Thomas A. D’Amico, David H. Harpole, and Andrew D. Shaw. “A randomized, double blind, placebo controlled clinical trial of the preoperative use of ketamine for reducing inflammation and pain after thoracic surgery.” J Anesth 25, no. 5 (October 2011): 672–78. https://doi.org/10.1007/s00540-011-1206-4.
       Full Text  Link to Item
    • Berry, Mark F., Mark W. Onaitis, Betty C. Tong, David H. Harpole, and Thomas A. D’Amico. “A model for morbidity after lung resection in octogenarians.” Eur J Cardiothorac Surg 39, no. 6 (June 2011): 989–94. https://doi.org/10.1016/j.ejcts.2010.09.038.
       Full Text  Link to Item
    • Harpole, W Stanley, and Katharine N. Suding. “A test of the niche dimension hypothesis in an arid annual grassland.” Oecologia 166, no. 1 (May 2011): 197–205. https://doi.org/10.1007/s00442-010-1808-9.
       Full Text  Link to Item
    • Onaitis, Mark, Thomas A. D’Amico, Cheryl P. Clark, Justin Guinney, David H. Harpole, and Emma L. Rawlins. “A 10-gene progenitor cell signature predicts poor prognosis in lung adenocarcinoma.” Ann Thorac Surg 91, no. 4 (April 2011): 1046–50. https://doi.org/10.1016/j.athoracsur.2010.12.054.
       Full Text  Link to Item
    • Berry, Mark F., B Zane Atkins, Betty C. Tong, David H. Harpole, Thomas A. D’Amico, and Mark W. Onaitis. “A comprehensive evaluation for aspiration after esophagectomy reduces the incidence of postoperative pneumonia.” J Thorac Cardiovasc Surg 140, no. 6 (December 2010): 1266–71. https://doi.org/10.1016/j.jtcvs.2010.08.038.
       Full Text  Link to Item
    • Cadotte, M. W., E. T. Borer, E. W. Seabloom, J. Cavender-Bares, W. S. Harpole, E. Cleland, and K. F. Davies. “Phylogenetic patterns differ for native and exotic plant communities across a richness gradient in Northern California.” Diversity and Distributions 16, no. 6 (November 1, 2010): 892–901. https://doi.org/10.1111/j.1472-4642.2010.00700.x.
       Full Text
    • Onaitis, Mark, Thomas D’Amico, Yue Zhao, Sean O’Brien, and David Harpole. “Risk factors for atrial fibrillation after lung cancer surgery: analysis of the Society of Thoracic Surgeons general thoracic surgery database.” Ann Thorac Surg 90, no. 2 (August 2010): 368–74. https://doi.org/10.1016/j.athoracsur.2010.03.100.
       Full Text  Link to Item
    • Berry, Mark F., Nestor R. Villamizar-Ortiz, Betty C. Tong, William R. Burfeind, David H. Harpole, Thomas A. D’Amico, and Mark W. Onaitis. “Pulmonary function tests do not predict pulmonary complications after thoracoscopic lobectomy.” Ann Thorac Surg 89, no. 4 (April 2010): 1044–51. https://doi.org/10.1016/j.athoracsur.2009.12.065.
       Full Text  Link to Item
    • Burfeind, William R., Nikhil P. Jaik, Nestor Villamizar, Eric M. Toloza, David H. Harpole, and Thomas A. D’Amico. “A cost-minimisation analysis of lobectomy: thoracoscopic versus posterolateral thoracotomy.” Eur J Cardiothorac Surg 37, no. 4 (April 2010): 827–32. https://doi.org/10.1016/j.ejcts.2009.10.017.
       Full Text  Link to Item
    • Paul, Subroto, Nasser K. Altorki, Shubin Sheng, Paul C. Lee, David H. Harpole, Mark W. Onaitis, Brendon M. Stiles, Jeffrey L. Port, and Thomas A. D’Amico. “Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: a propensity-matched analysis from the STS database.” J Thorac Cardiovasc Surg 139, no. 2 (February 2010): 366–78. https://doi.org/10.1016/j.jtcvs.2009.08.026.
       Full Text  Link to Item
    • Tong, Betty C., Jennifer Hanna, Eric M. Toloza, Mark W. Onaitis, Thomas A. D’Amico, David H. Harpole, and William R. Burfeind. “Outcomes of video-assisted thoracoscopic decortication.” Ann Thorac Surg 89, no. 1 (January 2010): 220–25. https://doi.org/10.1016/j.athoracsur.2009.09.021.
       Full Text  Link to Item
    • Berry, Mark F., Jennifer Hanna, Betty C. Tong, William R. Burfeind, David H. Harpole, Thomas A. D’Amico, and Mark W. Onaitis. “Risk factors for morbidity after lobectomy for lung cancer in elderly patients.” Ann Thorac Surg 88, no. 4 (October 2009): 1093–99. https://doi.org/10.1016/j.athoracsur.2009.06.012.
       Full Text  Link to Item
    • West, Howard, David Harpole, and William Travis. “Histologic considerations for individualized systemic therapy approaches for the management of non-small cell lung cancer.” Chest 136, no. 4 (October 2009): 1112–18. https://doi.org/10.1378/chest.08-2484.
       Full Text  Link to Item
    • West, Howard, Rogerio Lilenbaum, David Harpole, Antoinette Wozniak, and Lecia Sequist. “Molecular analysis-based treatment strategies for the management of non-small cell lung cancer.” J Thorac Oncol 4, no. 9 Suppl 2 (September 2009): S1029–39. https://doi.org/10.1097/JTO.0b013e3181b27170.
       Full Text  Link to Item
    • Villamizar, Nestor R., Marcus D. Darrabie, William R. Burfeind, Rebecca P. Petersen, Mark W. Onaitis, Eric Toloza, David H. Harpole, and Thomas A. D’Amico. “Thoracoscopic lobectomy is associated with lower morbidity compared with thoracotomy.” J Thorac Cardiovasc Surg 138, no. 2 (August 2009): 419–25. https://doi.org/10.1016/j.jtcvs.2009.04.026.
       Full Text  Link to Item
    • Onaitis, Mark W., Rebecca P. Petersen, John C. Haney, Leonard Saltz, Bernard Park, Raja Flores, Nabil Rizk, et al. “Prognostic factors for recurrence after pulmonary resection of colorectal cancer metastases.” Ann Thorac Surg 87, no. 6 (June 2009): 1684–88. https://doi.org/10.1016/j.athoracsur.2009.03.034.
       Full Text  Link to Item
    • Joshi, M. M., B. Seligmann, C. Sabalos, and D. H. Harpole. “Measurement of gene expression biomarkers by qNPA from archived NSCLC FFPE: Prognosis of 5-year survival.” J Clin Oncol 27, no. 15_suppl (May 20, 2009): 11098.
       Link to Item
    • Jones, Lee W., Neil D. Eves, Bercedis L. Peterson, Jennifer Garst, Jeffrey Crawford, Miranda J. West, Stephanie Mabe, David Harpole, William E. Kraus, and Pamela S. Douglas. “Safety and feasibility of aerobic training on cardiopulmonary function and quality of life in postsurgical nonsmall cell lung cancer patients: a pilot study.” Cancer 113, no. 12 (December 15, 2008): 3430–39. https://doi.org/10.1002/cncr.23967.
       Full Text  Link to Item
    • Strauss, Gary M., James E. Herndon, Michael A. Maddaus, David W. Johnstone, Elizabeth A. Johnson, David H. Harpole, Heidi H. Gillenwater, et al. “Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.” J Clin Oncol 26, no. 31 (November 1, 2008): 5043–51. https://doi.org/10.1200/JCO.2008.16.4855.
       Full Text  Link to Item
    • Burfeind, William R., Betty C. Tong, Erin O’Branski, James E. Herndon, Eric M. Toloza, Thomas A. D’Amico, Linda H. Harpole, and David H. Harpole. “Quality of life outcomes are equivalent after lobectomy in the elderly.” J Thorac Cardiovasc Surg 136, no. 3 (September 2008): 597–604. https://doi.org/10.1016/j.jtcvs.2008.02.093.
       Full Text  Link to Item
    • Kelsey, C. R., J. A. Boyd, J. L. Hubbs, D. R. Hollis, J. Crawford, N. E. Ready, T. A. D’Amcio, D. H. Harpole, J. Garst, and L. B. Marks. “Local/regional recurrence following surgery for early-stage lung cancer: A 10-year experience with 975 patients.” J Clin Oncol 26, no. 15_suppl (May 20, 2008): 7542.
       Link to Item
    • Atkins, B Zane, David H. Harpole, Jennifer H. Mangum, Eric M. Toloza, Thomas A. D’Amico, and William R. Burfeind. “Pulmonary segmentectomy by thoracotomy or thoracoscopy: reduced hospital length of stay with a minimally-invasive approach.” Ann Thorac Surg 84, no. 4 (October 2007): 1107–12. https://doi.org/10.1016/j.athoracsur.2007.05.013.
       Full Text  Link to Item
    • Hsu, David S., Bala S. Balakumaran, Chaitanya R. Acharya, Vanja Vlahovic, Kelli S. Walters, Katherine Garman, Carey Anders, et al. “Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancer.” J Clin Oncol 25, no. 28 (October 1, 2007): 4350–57. https://doi.org/10.1200/JCO.2007.11.0593.
       Full Text  Link to Item
    • Tong, Betty C., and David H. Harpole. “Audit, quality control, and performance in thoracic surgery: a North American perspective.” Thorac Surg Clin 17, no. 3 (August 2007): 379–86. https://doi.org/10.1016/j.thorsurg.2007.08.003.
       Full Text  Link to Item
    • Loewen, Gregory M., Dorothy Watson, Leslie Kohman, James E. Herndon, Hani Shennib, Kemp Kernstine, Jemi Olak, et al. “Preoperative exercise Vo2 measurement for lung resection candidates: results of Cancer and Leukemia Group B Protocol 9238.” J Thorac Oncol 2, no. 7 (July 2007): 619–25. https://doi.org/10.1097/JTO.0b013e318074bba7.
       Full Text  Link to Item
    • Harpole, David H. “Prognostic modeling in early stage lung cancer: an evolving process from histopathology to genomics.” Thorac Surg Clin 17, no. 2 (May 2007): 167–viii. https://doi.org/10.1016/j.thorsurg.2007.03.014.
       Full Text  Link to Item
    • Petersen, Rebecca P., DuyKhanh Pham, William R. Burfeind, Steven I. Hanish, Eric M. Toloza, David H. Harpole, and Thomas A. D’Amico. “Thoracoscopic lobectomy facilitates the delivery of chemotherapy after resection for lung cancer.” Ann Thorac Surg 83, no. 4 (April 2007): 1245–49. https://doi.org/10.1016/j.athoracsur.2006.12.029.
       Full Text  Link to Item
    • Czito, Brian G., Chris R. Kelsey, Herbert I. Hurwitz, Chris G. Willett, Michael A. Morse, Gerard C. Blobe, Nishan H. Fernando, et al. “A Phase I study of capecitabine, carboplatin, and paclitaxel with external beam radiation therapy for esophageal carcinoma.” Int J Radiat Oncol Biol Phys 67, no. 4 (March 15, 2007): 1002–7. https://doi.org/10.1016/j.ijrobp.2006.10.027.
       Full Text  Link to Item
    • Petersen, Rebecca P., Steven I. Hanish, John C. Haney, Charles C. Miller, William R. Burfeind, Douglas S. Tyler, Hilliard F. Seigler, Walter Wolfe, Thomas A. D’Amico, and David H. Harpole. “Improved survival with pulmonary metastasectomy: an analysis of 1720 patients with pulmonary metastatic melanoma.” J Thorac Cardiovasc Surg 133, no. 1 (January 2007): 104–10. https://doi.org/10.1016/j.jtcvs.2006.08.065.
       Full Text  Link to Item
    • Petersen, Rebecca P., Michael J. Campa, Justin Sperlazza, Debbi Conlon, Mary-Beth Joshi, David H. Harpole, and Edward F. Patz. “Tumor infiltrating Foxp3+ regulatory T-cells are associated with recurrence in pathologic stage I NSCLC patients.” Cancer 107, no. 12 (December 15, 2006): 2866–72. https://doi.org/10.1002/cncr.22282.
       Full Text  Link to Item
    • Harpole, David H., and Shari L. Meyerson. “Lung cancer staging: proteomics.” Thorac Surg Clin 16, no. 4 (November 2006): 339–43. https://doi.org/10.1016/j.thorsurg.2006.10.001.
       Full Text  Link to Item
    • Lemaire, Anthony, Ivana Nikolic, Thomas Petersen, Jack C. Haney, Eric M. Toloza, David H. Harpole, Thomas A. D’Amico, and William R. Burfeind. “Nine-year single center experience with cervical mediastinoscopy: complications and false negative rate.” Ann Thorac Surg 82, no. 4 (October 2006): 1185–89. https://doi.org/10.1016/j.athoracsur.2006.05.023.
       Full Text  Link to Item
    • Posther, Katherine E., Linda M. McCall, David H. Harpole, Carolyn E. Reed, Joe B. Putnam, Valerie W. Rusch, and Barry A. Siegel. “Yield of brain 18F-FDG PET in evaluating patients with potentially operable non-small cell lung cancer.” J Nucl Med 47, no. 10 (October 2006): 1607–11.
       Link to Item
    • Onaitis, Mark W., Rebecca P. Petersen, Stafford S. Balderson, Eric Toloza, William R. Burfeind, David H. Harpole, and Thomas A. D’Amico. “Thoracoscopic lobectomy is a safe and versatile procedure: experience with 500 consecutive patients.” Ann Surg 244, no. 3 (September 2006): 420–25. https://doi.org/10.1097/01.sla.0000234892.79056.63.
       Full Text  Link to Item
    • Potti, Anil, Sayan Mukherjee, Rebecca Petersen, Holly K. Dressman, Andrea Bild, Jason Koontz, Robert Kratzke, et al. “A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer.” N Engl J Med 355, no. 6 (August 10, 2006): 570–80. https://doi.org/10.1056/NEJMoa060467.
       Full Text  Link to Item
    • Dressman, Holly K., Andrea Bild, Jennifer Garst, David Harpole, and Anil Potti. “Genomic signatures in non-small-cell lung cancer: targeting the targeted therapies.” Curr Oncol Rep 8, no. 4 (July 2006): 252–57. https://doi.org/10.1007/s11912-006-0029-1.
       Full Text  Link to Item
    • Petersen, Rebecca P., Duykhanh Pham, Eric M. Toloza, William R. Burfeind, David H. Harpole, Steven I. Hanish, and Thomas A. D’Amico. “Thoracoscopic lobectomy: a safe and effective strategy for patients receiving induction therapy for non-small cell lung cancer.” Ann Thorac Surg 82, no. 1 (July 2006): 214–18. https://doi.org/10.1016/j.athoracsur.2006.02.051.
       Full Text  Link to Item
    • Petersen, Rebecca P., and David H. Harpole. “Computed tomography screening for the early detection of lung cancer.” J Natl Compr Canc Netw 4, no. 6 (July 2006): 591–94. https://doi.org/10.6004/jnccn.2006.0048.
       Full Text  Link to Item
    • Harpole, D. H., M. M. Joshi, R. P. Petersen, D. H. Conlon, K. Tanaka, D. Shimizu, H. Kuramochi, M. Williams, P. V. Danenberg, and K. Danenberg. “A lung cancer genomic risk prediction model derived from paraffin-embedded tissue.” J Clin Oncol 24, no. 18_suppl (June 20, 2006): 10059.
       Link to Item
    • Harpole, D. H., R. Petersen, S. Mukherjee, A. Bild, H. Dressman, R. Kratzke, M. J. Kelley, et al. “A genomic strategy to refine prognosis in early stage non-small cell lung carcinoma (NSCLC).” J Clin Oncol 24, no. 18_suppl (June 20, 2006): 7026.
       Link to Item
    • Joshi, M. M., R. P. Petersen, D. H. Conlon, K. Tanaka, D. Shimizu, H. Kuramochi, M. Williams, P. V. Danenberg, K. D. Danenberg, and D. H. Harpole. “Differential canonical pathways derived from microarrays using RNA from paraffin-embedded non-small cell lung cancer tissue.” J Clin Oncol 24, no. 18_suppl (June 20, 2006): 7226.
       Link to Item
    • D’Amico, Thomas A., Kelli R. Brooks, Mary-Beth Moore Joshi, Debbi Conlon, James Herndon, Rebecca P. Petersen, and David H. Harpole. “Serum protein expression predicts recurrence in patients with early-stage lung cancer after resection.” Ann Thorac Surg 81, no. 6 (June 2006): 1982–87. https://doi.org/10.1016/j.athoracsur.2006.01.042.
       Full Text  Link to Item
    • Allen, Mark S., Gail E. Darling, Taine T. V. Pechet, John D. Mitchell, James E. Herndon, Rodney J. Landreneau, Richard I. Inculet, et al. “Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial.” Ann Thorac Surg 81, no. 3 (March 2006): 1013–19. https://doi.org/10.1016/j.athoracsur.2005.06.066.
       Full Text  Link to Item
    • Gaca, Jeffrey G., Rebecca P. Petersen, Bercedis L. Peterson, David H. Harpole, Thomas A. D’Amico, Theodore N. Pappas, Hilliard F. Seigler, Walter G. Wolfe, and Douglas S. Tyler. “Pathologic nodal status predicts disease-free survival after neoadjuvant chemoradiation for gastroesophageal junction carcinoma.” Ann Surg Oncol 13, no. 3 (March 2006): 340–46. https://doi.org/10.1245/ASO.2006.02.023.
       Full Text  Link to Item
    • Posther, Katherine E., and David H. Harpole. “The surgical management of lung cancer.” Cancer Invest 24, no. 1 (February 2006): 56–67. https://doi.org/10.1080/07357900500449611.
       Full Text  Link to Item
    • Bild, Andrea H., Guang Yao, Jeffrey T. Chang, Quanli Wang, Anil Potti, Dawn Chasse, Mary-Beth Joshi, et al. “Oncogenic pathway signatures in human cancers as a guide to targeted therapies.” Nature 439, no. 7074 (January 19, 2006): 353–57. https://doi.org/10.1038/nature04296.
       Full Text  Link to Item
    • Burfeind, William R., Thomas A. D’Amico, Eric M. Toloza, Walter G. Wolfe, and David H. Harpole. “Low morbidity and mortality for bronchoplastic procedures with and without induction therapy.” Ann Thorac Surg 80, no. 2 (August 2005): 418–21. https://doi.org/10.1016/j.athoracsur.2005.02.058.
       Full Text  Link to Item
    • Lemaire, Anthony, William R. Burfeind, Eric Toloza, Scott Balderson, Rebecca P. Petersen, David H. Harpole, and Thomas A. D’Amico. “Outcomes of tracheobronchial stents in patients with malignant airway disease.” Ann Thorac Surg 80, no. 2 (August 2005): 434–37. https://doi.org/10.1016/j.athoracsur.2005.02.071.
       Full Text  Link to Item
    • Petersen, R. P., A. Bild, H. Dressman, M. M. Joshi, D. H. Conlon, M. West, J. R. Nevins, and D. H. Harpole. “Gene expression signatures for prognosis in NSCLC, coupled with signatures of oncogenic pathway deregulation, provide a novel approach for selection of molecular targets.” J Clin Oncol 23, no. 16_suppl (June 2005): 7020.
       Link to Item
    • D’Cunha, Jonathan, James E. Herndon, Debra L. Herzan, G Alexander Patterson, Leslie J. Kohman, David H. Harpole, Kemp H. Kernstine, et al. “Poor correspondence between clinical and pathologic staging in stage 1 non-small cell lung cancer: results from CALGB 9761, a prospective trial.” Lung Cancer 48, no. 2 (May 2005): 241–46. https://doi.org/10.1016/j.lungcan.2004.11.006.
       Full Text  Link to Item
    • Joshi, Mary-Beth Moore, Yoshinori Shirota, Kathleen D. Danenberg, Debbi H. Conlon, Dennis S. Salonga, James E. Herndon, Peter V. Danenberg, and David H. Harpole. “High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancer.” Clin Cancer Res 11, no. 6 (March 15, 2005): 2215–21. https://doi.org/10.1158/1078-0432.CCR-04-1387.
       Full Text  Link to Item
    • Burfeind, William R., and David H. Harpole. “Surgical strategies and outcomes after induction therapy for non-small cell lung cancer.” Semin Thorac Cardiovasc Surg 17, no. 3 (2005): 186–90. https://doi.org/10.1053/j.semtcvs.2005.06.015.
       Full Text  Link to Item
    • Atkins, B Zane, Ashish S. Shah, Kelley A. Hutcheson, Jennifer H. Mangum, Theodore N. Pappas, David H. Harpole, and Thomas A. D’Amico. “Reducing hospital morbidity and mortality following esophagectomy.” Ann Thorac Surg 78, no. 4 (October 2004): 1170–76. https://doi.org/10.1016/j.athoracsur.2004.02.034.
       Full Text  Link to Item
    • Allen, Mark S., Douglas E. Wood, Ronald W. Hawkinson, David H. Harpole, Robert J. McKenna, Garrett L. Walsh, Eric Vallieres, et al. “Prospective randomized study evaluating a biodegradable polymeric sealant for sealing intraoperative air leaks that occur during pulmonary resection.” Ann Thorac Surg 77, no. 5 (May 2004): 1792–1801. https://doi.org/10.1016/j.athoracsur.2003.10.049.
       Full Text  Link to Item
    • McKenna, Robert J., Joshua O. Benditt, Malcolm DeCamp, Claude Deschamps, Larry Kaiser, Shing M. Lee, Zab Mohsenifar, et al. “Safety and efficacy of median sternotomy versus video-assisted thoracic surgery for lung volume reduction surgery.” J Thorac Cardiovasc Surg 127, no. 5 (May 2004): 1350–60. https://doi.org/10.1016/j.jtcvs.2003.11.025.
       Full Text  Link to Item
    • Rizzo, Marco, S Scott Balderson, David H. Harpole, and L Scott Levin. “Thoracoscopic sympathectomy in the management of vasomotor disturbances and complex regional pain syndrome of the hand.” Orthopedics 27, no. 1 (January 2004): 49–52. https://doi.org/10.3928/0147-7447-20040101-18.
       Full Text  Link to Item
    • Reed, Carolyn E., David H. Harpole, Katherine E. Posther, Sandra L. Woolson, Robert J. Downey, Bryan F. Meyers, Robert T. Heelan, et al. “Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer.” J Thorac Cardiovasc Surg 126, no. 6 (December 2003): 1943–51. https://doi.org/10.1016/j.jtcvs.2003.07.030.
       Full Text  Link to Item
    • Ghanayem, N. S., G. M. Hoffman, K. A. Mussatto, J. R. Cava, P. C. Frommelt, N. A. Rudd, M. M. Steltzer, et al. “Home surveillance program prevents interstage mortality after the Norwood procedure.” J Thorac Cardiovasc Surg 126, no. 5 (November 2003): 1367–77. https://doi.org/10.1016/s0022-5223(03)00071-0.
       Full Text  Link to Item
    • Brooks, Kelli R., Kathleen To, Mary-Beth Moore Joshi, Debbi H. Conlon, James E. Herndon, Thomas A. D’Amico, and David H. Harpole. “Measurement of chemoresistance markers in patients with stage III non-small cell lung cancer: a novel approach for patient selection.” Ann Thorac Surg 76, no. 1 (July 2003): 187–93. https://doi.org/10.1016/s0003-4975(03)00131-0.
       Full Text  Link to Item
    • Rentz, Jeffrey, David Bull, David Harpole, Stephen Bailey, Leigh Neumayer, Theodore Pappas, Barbara Krasnicka, William Henderson, Jennifer Daley, and Shukri Khuri. “Transthoracic versus transhiatal esophagectomy: a prospective study of 945 patients.” J Thorac Cardiovasc Surg 125, no. 5 (May 2003): 1114–20. https://doi.org/10.1067/mtc.2003.315.
       Full Text  Link to Item
    • Kinch, Michael S., Mary-Beth Moore, and David H. Harpole. “Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survival.” Clin Cancer Res 9, no. 2 (February 2003): 613–18.
       Link to Item
    • Joshi, Mary-Beth Moore, Thomas A. D’Amico, and David H. Harpole. “Molecular biologic substaging of stage I NSCLC through immunohistochemistry performed on formalin-fixed, paraffin-embedded tissue.” Methods Mol Med 75 (2003): 369–88.
       Link to Item
    • Bailey, Stephen H., David A. Bull, David H. Harpole, Jeffrey J. Rentz, Leigh A. Neumayer, Theodore N. Pappas, Jennifer Daley, William G. Henderson, Barbara Krasnicka, and Shukri F. Khuri. “Outcomes after esophagectomy: a ten-year prospective cohort.” Ann Thorac Surg 75, no. 1 (January 2003): 217–22. https://doi.org/10.1016/s0003-4975(02)04368-0.
       Full Text  Link to Item
    • Toloza, Eric M., and David H. Harpole. “Intraoperative techniques to prevent air leaks.” Chest Surg Clin N Am 12, no. 3 (August 2002): 489–505. https://doi.org/10.1016/s1052-3359(02)00020-0.
       Full Text  Link to Item
    • D’Amico, Thomas A., Terence Z. Wong, David H. Harpole, Stephen D. Brown, and R Edward Coleman. “Impact of computed tomography-positron emission tomography fusion in staging patients with thoracic malignancies.” Ann Thorac Surg 74, no. 1 (July 2002): 160–63. https://doi.org/10.1016/s0003-4975(02)03693-7.
       Full Text  Link to Item
    • Lau, Christine L., Mary-Beth H. Moore, Kelly R. Brooks, Thomas A. D’Amico, and David H. Harpole. “Molecular staging of lung and esophageal cancer.” Surg Clin North Am 82, no. 3 (June 2002): 497–523. https://doi.org/10.1016/s0039-6109(02)00024-5.
       Full Text  Link to Item
    • Lewis, Cleveland W., and David Harpole. “Pulmonary metastasectomy for metastatic malignant melanoma.” Semin Thorac Cardiovasc Surg 14, no. 1 (January 2002): 45–48. https://doi.org/10.1053/stcs.2002.31741.
       Full Text  Link to Item
    • Kelley, M. J., S. Li, and D. H. Harpole. “Genetic analysis of the beta-tubulin gene, TUBB, in non-small-cell lung cancer.” J Natl Cancer Inst 93, no. 24 (December 19, 2001): 1886–88. https://doi.org/10.1093/jnci/93.24.1886.
       Full Text  Link to Item
    • D’Amico, T. A., T. A. Aloia, M. B. Moore, D. H. Conlon, J. E. Herndon, M. S. Kinch, and D. H. Harpole. “Predicting the sites of metastases from lung cancer using molecular biologic markers.” Ann Thorac Surg 72, no. 4 (October 2001): 1144–48. https://doi.org/10.1016/s0003-4975(01)02979-4.
       Full Text  Link to Item
    • Aloia, T. A., D. H. Harpole, C. E. Reed, C. Allegra, M. B. Moore, J. E. Herndon, and T. A. D’Amico. “Tumor marker expression is predictive of survival in patients with esophageal cancer.” Ann Thorac Surg 72, no. 3 (September 2001): 859–66. https://doi.org/10.1016/s0003-4975(01)02838-7.
       Full Text  Link to Item
    • Marom, E. M., T. A. Aloia, M. B. Moore, M. Hara, J. E. Herndon, D. H. Harpole, P. C. Goodman, and E. F. Patz. “Correlation of FDG-PET imaging with Glut-1 and Glut-3 expression in early-stage non-small cell lung cancer.” Lung Cancer 33, no. 2–3 (August 2001): 99–107. https://doi.org/10.1016/s0169-5002(00)00250-6.
       Full Text  Link to Item
    • Salgia, R., D. Harpole, J. E. Herndon, E. Pisick, A. Elias, and A. T. Skarin. “Role of serum tumor markers CA 125 and CEA in non-small cell lung cancer.” Anticancer Research 21, no. 2 B (June 11, 2001): 1241–46.
    • Harris, L. N., V. Liotcheva, G. Broadwater, M. J. Ramirez, P. Maimonis, S. Anderson, T. Everett, et al. “Comparison of methods of measuring HER-2 in metastatic breast cancer patients treated with high-dose chemotherapy.” J Clin Oncol 19, no. 6 (March 15, 2001): 1698–1706. https://doi.org/10.1200/JCO.2001.19.6.1698.
       Full Text  Link to Item
    • Harpole, D. H., M. B. Moore, J. E. Herndon, T. Aloia, T. A. D’Amico, T. Sporn, A. Parr, I. Linoila, and C. Allegra. “The prognostic value of molecular marker analysis in patients treated with trimodality therapy for esophageal cancer.” Clin Cancer Res 7, no. 3 (March 2001): 562–69.
       Link to Item
    • Aloia, T., G. Bepler, D. Harpole, P. C. Goodman, H. P. McAdams, J. J. Erasmus, J. E. Herndon, and E. F. Patz. “Integration of peripheral blood biomarkers with computed tomography to differentiate benign from malignant pulmonary opacities.” Cancer Detect Prev 25, no. 4 (2001): 336–43.
       Link to Item
    • Kawakami, K., J. Brabender, R. V. Lord, S. Groshen, B. D. Greenwald, M. J. Krasna, J. Yin, et al. “Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma.” J Natl Cancer Inst 92, no. 22 (November 15, 2000): 1805–11. https://doi.org/10.1093/jnci/92.22.1805.
       Full Text  Link to Item
    • Lau, C. L., D. H. Harpole, and E. Patz. “Staging techniques for lung cancer.” Chest Surg Clin N Am 10, no. 4 (November 2000): 781–801.
       Link to Item
    • D’Amico, T. A., and D. H. Harpole. “Molecular biology of esophageal cancer.” Chest Surg Clin N Am 10, no. 3 (August 2000): 451–69.
       Link to Item
    • Patz, E. F., S. Rossi, D. H. Harpole, J. E. Herndon, and P. C. Goodman. “Correlation of tumor size and survival in patients with stage IA non-small cell lung cancer.” Chest 117, no. 6 (June 2000): 1568–71. https://doi.org/10.1378/chest.117.6.1568.
       Full Text  Link to Item
    • D’Amico, T. A., T. A. Aloia, M. B. Moore, J. E. Herndon, K. R. Brooks, C. L. Lau, and D. H. Harpole. “Molecular biologic substaging of stage I lung cancer according to gender and histology.” Ann Thorac Surg 69, no. 3 (March 2000): 882–86. https://doi.org/10.1016/s0003-4975(99)01522-2.
       Full Text  Link to Item
    • Lau, C. L., and D. H. Harpole. “Noninvasive clinical staging modalities for lung cancer.” Semin Surg Oncol 18, no. 2 (March 2000): 116–23. https://doi.org/10.1002/(sici)1098-2388(200003)18:2<116::aid-ssu5>3.0.co;2-l.
       Full Text  Link to Item
    • “Rationale and design of The National Emphysema Treatment Trial: a prospective randomized trial of lung volume reduction surgery. The National Emphysema Treatment Trial Research Group.” Chest 116, no. 6 (December 1999): 1750–61. https://doi.org/10.1378/chest.116.6.1750.
       Full Text  Link to Item
    • Grichnik, K. P., A. J. Ijsselmuiden, T. A. D’Amico, D. H. Harpole, W. D. White, J. A. Blumenthal, and M. F. Newman. “Cognitive decline after major noncardiac operations: a preliminary prospective study.” Ann Thorac Surg 68, no. 5 (November 1999): 1786–91. https://doi.org/10.1016/s0003-4975(99)00992-3.
       Full Text  Link to Item
    • Rodarte, J., C. Miller, P. Barnard, J. Carter, K. DuBose, D. Harpole, and al et. “Rationale and design of the national emphysema treatment trial (NETT): A prospective randomized trial of lung volume reduction surgery.” Edited by J. Rodarte, C. Miller, P. Barnard, J. Carter, K. DuBose, and D. Harpole. The Journal of Thoracic and Cardiovascular Surgery 118, no. 3 (September 1999): 518–28. https://doi.org/10.1016/S0022-5223(99)70191-1.
       Full Text
    • D’Amico, T. A., M. Massey, J. E. Herndon, M. B. Moore, and D. H. Harpole. “A biologic risk model for stage I lung cancer: immunohistochemical analysis of 408 patients with the use of ten molecular markers.” J Thorac Cardiovasc Surg 117, no. 4 (April 1999): 736–43. https://doi.org/10.1016/s0022-5223(99)70294-1.
       Full Text  Link to Item
    • Kwiatkowski, D. J., D. H. Harpole, J. Godleski, J. E. Herndon, D. B. Shieh, W. Richards, R. Blanco, H. J. Xu, G. M. Strauss, and D. J. Sugarbaker. “Molecular pathologic substaging in 244 stage I non-small-cell lung cancer patients: clinical implications.” J Clin Oncol 16, no. 7 (July 1998): 2468–77. https://doi.org/10.1200/JCO.1998.16.7.2468.
       Full Text  Link to Item
    • Clary, B., L. Skaryak, M. Tedder, A. Hilton, G. Botz, and D. Harpole. “Methemoglobinemia complicating topical anesthesia during bronchoscopic procedures.” J Thorac Cardiovasc Surg 114, no. 2 (August 1997): 293–95. https://doi.org/10.1016/S0022-5223(97)70163-6.
       Full Text  Link to Item
    • Harpole, D. H., S. A. Gall, W. G. Wolfe, J. S. Rankin, and R. H. Jones. “Effects of valve replacement on ventricular mechanics in mitral regurgitation and aortic stenosis.” Ann Thorac Surg 62, no. 3 (September 1996): 756–61. https://doi.org/10.1016/s0003-4975(96)00378-5.
       Full Text  Link to Item
    • Jaklitsch, M. T., M. M. DeCamp, M. J. Liptay, D. H. Harpole, S. J. Swanson, S. J. Mentzer, and D. J. Sugarbaker. “Video-assisted thoracic surgery in the elderly. A review of 307 cases.” Chest 110, no. 3 (September 1996): 751–58. https://doi.org/10.1378/chest.110.3.751.
       Full Text  Link to Item
    • Sugarbaker, D. J., J. P. Garcia, W. G. Richards, D. H. Harpole, E. Healy-Baldini, M. M. DeCamp, S. J. Mentzer, M. J. Liptay, G. M. Strauss, and S. J. Swanson. “Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients.” Ann Surg 224, no. 3 (September 1996): 288–94. https://doi.org/10.1097/00000658-199609000-00005.
       Full Text  Link to Item
    • Harpole, D. H., W. G. Richards, J. E. Herndon, and D. J. Sugarbaker. “Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer.” Ann Thorac Surg 61, no. 5 (May 1996): 1470–76. https://doi.org/10.1016/0003-4975(96)00104-X.
       Full Text  Link to Item
    • Harpole, D. H., J. E. Herndon, W. G. Young, W. G. Wolfe, and D. C. Sabiston. “Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence.” Cancer 76, no. 5 (September 1, 1995): 787–96. https://doi.org/10.1002/1097-0142(19950901)76:5<787::aid-cncr2820760512>3.0.co;2-q.
       Full Text  Link to Item
    • DeCamp, M. M., M. T. Jaklitsch, S. J. Mentzer, D. H. Harpole, and D. J. Sugarbaker. “The safety and versatility of video-thoracoscopy: a prospective analysis of 895 consecutive cases.” J Am Coll Surg 181, no. 2 (August 1995): 113–20.
       Link to Item
    • Harpole, D. H., J. R. Marks, W. G. Richards, J. E. Herndon, and D. J. Sugarbaker. “Localized adenocarcinoma of the lung: oncogene expression of erbB-2 and p53 in 150 patients.” Clin Cancer Res 1, no. 6 (June 1995): 659–64.
       Link to Item
    • Strauss, G. M., D. J. Kwiatkowski, D. H. Harpole, T. J. Lynch, A. T. Skarin, and D. J. Sugarbaker. “Molecular and pathologic markers in stage I non-small-cell carcinoma of the lung.” J Clin Oncol 13, no. 5 (May 1995): 1265–79. https://doi.org/10.1200/JCO.1995.13.5.1265.
       Full Text  Link to Item
    • Harpole, D. H., J. E. Herndon, W. G. Wolfe, J. D. Iglehart, and J. R. Marks. “A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression.” Cancer Res 55, no. 1 (January 1, 1995): 51–56.
       Link to Item
    • Jaklitsch, M. T., D. H. Harpole, E. A. Healey, and D. J. Sugarbaker. “Current Issues in the Staging of Esophageal Cancer.” Semin Radiat Oncol 4, no. 3 (July 1994): 135–45. https://doi.org/10.1053/SRAO00400135.
       Full Text  Link to Item
    • Harpole, D. H., and R. H. Jones. “Left ventricular function under stress before and after myocardial revascularization.” Am Heart J 124, no. 2 (August 1992): 273–79. https://doi.org/10.1016/0002-8703(92)90587-l.
       Full Text  Link to Item
    • Harpole, D. H., J. M. Feldman, S. Buchanan, W. G. Young, and W. G. Wolfe. “Bronchial carcinoid tumors: a retrospective analysis of 126 patients.” Ann Thorac Surg 54, no. 1 (July 1992): 50–54. https://doi.org/10.1016/0003-4975(92)91139-z.
       Full Text  Link to Item
    • Harpole, D. H., C. M. Johnson, W. G. Wolfe, S. L. George, and H. F. Seigler. “Analysis of 945 cases of pulmonary metastatic melanoma.” J Thorac Cardiovasc Surg 103, no. 4 (April 1992): 743–48.
       Link to Item
    • Harpole, D. H., C. J. Davidson, T. N. Skelton, K. B. Kisslo, R. H. Jones, and T. M. Bashore. “Early and late changes in left ventricular systolic performance after percutaneous aortic balloon valvuloplasty.” Am J Cardiol 66, no. 3 (August 1, 1990): 327–32. https://doi.org/10.1016/0002-9149(90)90844-q.
       Full Text  Link to Item
    • Harpole, D. H., J. S. Rankin, W. G. Wolfe, F. M. Clements, P. Van Trigt, W. G. Young, and R. H. Jones. “Effects of standard mitral valve replacement on left ventricular function.” Ann Thorac Surg 49, no. 6 (June 1990): 866–73. https://doi.org/10.1016/0003-4975(90)90858-4.
       Full Text  Link to Item
    • Harpole, D. H., C. J. Davidson, T. N. Skelton, K. B. Kisslo, R. H. Jones, and T. M. Bashore. “Changes in left ventricular systolic performance immediately after percutaneous aortic balloon valvuloplasty.” Am J Cardiol 65, no. 18 (May 15, 1990): 1213–18. https://doi.org/10.1016/0002-9149(90)90976-8.
       Full Text  Link to Item
    • Harpole, D. H., and R. H. Jones. “Serial assessment of ventricular performance after valve replacement for aortic stenosis.” J Thorac Cardiovasc Surg 99, no. 4 (April 1990): 645–50.
       Link to Item
    • Clements, F. M., D. H. Harpole, T. Quill, R. H. Jones, and R. L. McCann. “Estimation of left ventricular volume and ejection fraction by two-dimensional transoesophageal echocardiography: comparison of short axis imaging and simultaneous radionuclide angiography.” Br J Anaesth 64, no. 3 (March 1990): 331–36. https://doi.org/10.1093/bja/64.3.331.
       Full Text  Link to Item
    • Harpole, D. H., C. Davidson, T. Skelton, R. H. Jones, and T. M. Bashore. “Serial evaluation of ventricular function after percutaneous aortic balloon valvuloplasty.” Am Heart J 119, no. 1 (January 1990): 130–35. https://doi.org/10.1016/s0002-8703(05)80092-4.
       Full Text  Link to Item
    • Harpole, D. H., J. S. Rankin, W. G. Wolfe, L. R. Smith, W. G. Young, F. M. Clements, and R. H. Jones. “Assessment of left ventricular functional preservation during isolated cardiac valve operations.” Circulation 80, no. 5 Pt 2 (November 1989): III1–9.
       Link to Item
    • Harpole, D. H., F. M. Clements, T. Quill, W. G. Wolfe, R. H. Jones, and R. L. McCann. “Right and left ventricular performance during and after abdominal aortic aneurysm repair.” Ann Surg 209, no. 3 (March 1989): 356–62. https://doi.org/10.1097/00000658-198903000-00017.
       Full Text  Link to Item
    • Davidson, C. J., D. A. Harpole, K. Kisslo, T. N. Skelton, J. Kisslo, R. H. Jones, and T. M. Bashore. “Analysis of the early rise in aortic transvalvular gradient after aortic valvuloplasty.” Am Heart J 117, no. 2 (February 1989): 411–17. https://doi.org/10.1016/0002-8703(89)90788-6.
       Full Text  Link to Item
    • Harpole, D. H., C. Bigelow, W. G. Young, W. G. Wolfe, and D. C. Sabiston. “Alveolar cell carcinoma of the lung: a retrospective analysis of 205 patients.” Ann Thorac Surg 46, no. 5 (November 1988): 502–7. https://doi.org/10.1016/s0003-4975(10)64685-1.
       Full Text  Link to Item
    • Wanebo, H. J., P. H. Cooper, D. V. Young, D. H. Harpole, and D. L. Kaiser. “Prognostic factors in head and neck melanoma. Effect of lesion location.” Cancer 62, no. 4 (August 15, 1988): 831–37. https://doi.org/10.1002/1097-0142(19880815)62:4<831::aid-cncr2820620432>3.0.co;2-x.
       Full Text  Link to Item
    • Wanebo, H. J., D. Harpole, and C. D. Teates. “Radionuclide lymphoscintigraphy with technetium 99m antimony sulfide colloid to identify lymphatic drainage of cutaneous melanoma at ambiguous sites in the head and neck and trunk.” Cancer 55, no. 6 (March 15, 1985): 1403–13. https://doi.org/10.1002/1097-0142(19850315)55:6<1403::aid-cncr2820550640>3.0.co;2-k.
       Full Text  Link to Item
    • OCHSNER, A., and D. H. HARPOLE. “Malignant melanoma. Its prognosis as influenced by therapy.” Ann Surg 155 (May 1962): 629–38. https://doi.org/10.1097/00000658-196205000-00002.
       Full Text  Link to Item
    • Welp, Annalyn M., Sarah E. Abbott, Pamela Samson, Robert B. Cameron, Lorraine D. Cornwell, David Harpole, and Drew Moghanaki. “The Quality of Peer-Reviewed Publications on Surgery for Early Stage Lung Cancer Within the Veterans Health Administration.” Semin Thorac Cardiovasc Surg 32, no. 4 (n.d.): 1066–73. https://doi.org/10.1053/j.semtcvs.2020.04.004.
       Full Text  Link to Item

  • Book Sections

    • Tong, B. C., and D. H. Harpole. “Molecular prognostication of lung cancer.” In Principles and Practice of Lung Cancer: The Official Reference Text of the International Association for the Study of Lung Cancer (IASLC): Fourth Edition, 147–62, 2012.
    • Harpole, D. H., and M. Onaitis. “Present concepts in the molecular biology of lung cancer.” In General Thoracic Surgery: Seventh Edition, 2–2:3577–91, 2011.
    • Meyerson, S. L., and D. A. Harpole. “Mycotic and actinomycetic infections of the lung.” In General Thoracic Surgery: Seventh Edition, 1–2:3077–3128, 2011.
    • Meyerson, S. L., and D. A. Harpole. “Anatomy of the thorax.” In General Thoracic Surgery: Seventh Edition, 1–2:76–102, 2011.
    • Meyerson, S. L., and D. H. Harpole. “Induction therapy for stage IIIA (N2) lung cancer.” In Difficult Decisions in Thoracic Surgery: An Evidence-Based Approach, 88–93, 2007. https://doi.org/10.1007/978-1-84628-474-8_10.
       Full Text

  • Other Articles

    • Burt, Brian, Brian Kubasiak, and David H. Harpole. “Value of circulating insulin-like growth factor-associated proteins for the detection of stage I non-small cell lung cancer Discussion.” Journal of Thoracic and Cardiovascular Surgery. MOSBY-ELSEVIER, March 1, 2015.
       Link to Item
    • Rao, Vivek, Kindi Al, David H. Harpole, and Todd K. Rosengart. “Sustained release of milrinone delivered via microparticles in a rodent model of myocardial infarction Discussion.” Journal of Thoracic and Cardiovascular Surgery. MOSBY-ELSEVIER, November 1, 2014.
       Link to Item
    • Coles, John G., Kim Mr, Peter Mckeown, David H. Harpole, and Carl L. Backer. “Patient Genotypes Impact Survival After Surgery for Isolated Congenital Heart Disease DISCUSSION.” Annals of Thoracic Surgery. ELSEVIER SCIENCE INC, July 1, 2014.
       Link to Item
    • Harpole, David H., Scott J. Swanson, Ginsburg Dr, Akif Turna, and Malcolm M. Decamp. “Lung Volume Reduction Surgery Using the NETT Selection Criteria DISCUSSION.” Annals of Thoracic Surgery. ELSEVIER SCIENCE INC, May 1, 2011.
       Link to Item
    • Potti, Anil, Sayan Mukherjee, Rebecca Petersen, Holly K. Dressman, Andrea Bild, Jason Koontz, Robert Kratzke, et al. “Retraction: A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N Engl J Med 2006;355:570-80.” N Engl J Med, March 24, 2011. https://doi.org/10.1056/NEJMc1101915.
       Full Text  Link to Item
    • Berry, M. F., Z. Atkins, B. C. Tong, D. H. Harpole, T. A. D’Amico, and M. W. Onaitis. “A comprehensive evaluation for aspiration after esophagectomy reduces the incidence of postoperative pneumonia.” Dysphagia, 2011. https://doi.org/10.1007/s00455-011-9343-3.
       Full Text
    • “Retraction. Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancer. J Clin Oncol 25:4350–7, 2007.” J Clin Oncol, December 10, 2010. https://doi.org/10.1200/JCO.2010.33.7311.
       Full Text  Link to Item
    • Krasna, Mark J., Mark J. Kim, David H. Harpole, Paul Henry Schipper, and Donald E. Low. “Pathologic T0N1 Esophageal Cancer After Neoadjuvant Therapy and Surgery: An Orphan Status DISCUSSION.” Annals of Thoracic Surgery. ELSEVIER SCIENCE INC, September 1, 2010.
       Link to Item
    • Swanson, Scott J., Scott J. Seely, David H. Harpole, and Mark I. Block. “Systematic Classification of Morbidity and Mortality After Thoracic Surgery DISCUSSION.” Annals of Thoracic Surgery. ELSEVIER SCIENCE INC, September 1, 2010.
       Link to Item
    • Harpole, D. H., M. P. Poullis, M. M. Decamp, and S. C. Murthy. “Discussion.” Annals of Thoracic Surgery, January 1, 2010. https://doi.org/10.1016/j.athoracsur.2010.04.100.
       Full Text
    • Krasna, M. J., D. H. Harpole, P. H. Schipper, and D. E. Low. “Discussion.” Annals of Thoracic Surgery, January 1, 2010. https://doi.org/10.1016/j.athoracsur.2010.03.116.
       Full Text
    • Swanson, S. J., H. H. David, and M. I. Block. “Discussion.” Annals of Thoracic Surgery, January 1, 2010. https://doi.org/10.1016/j.athoracsur.2010.05.014.
       Full Text
    • Kim, Woo Jin, Edwin K. Silverman, Eric Hoffman, Gerard J. Criner, Zab Mosenifar, Frank C. Sciurba, Barry J. Make, et al. “CT metrics of airway disease and emphysema in severe COPD.” Chest, August 2009. https://doi.org/10.1378/chest.08-2858.
       Full Text  Link to Item
    • Pham, DuyKhanh, and David H. Harpole. “Stage I NSCLC: elucidating the prognostic factors.” Thorax, March 2009. https://doi.org/10.1136/thx.2008.105965.
       Full Text  Link to Item
    • Potti, A., H. K. Dressman, A. Bild, R. F. Riedel, G. Chan, R. Sayer, J. Cragun, et al. “Corrigendum: Genomic signatures to guide the use of chemotherapeutics (Nature Medicine (2006) 12, (1294-1300)).” Nature Medicine, August 1, 2008. https://doi.org/10.1038/nm0808-889.
       Full Text
    • Potti, A., H. K. Dressman, A. Bild, R. F. Riedel, G. Chan, R. Sayer, J. Cragun, et al. “Erratum: Genomic signatures to guide the use of chemotherapeutics (Nature (2006) 12, (1294-1300)).” Nature Medicine, November 1, 2007. https://doi.org/10.1038/nm1107-1388.
       Full Text
    • Reed, C. E., D. H. Harpole, K. E. Posther, S. L. Woolson, R. J. Downey, and B. R. Meyers. “Results of ACOSOG Z0050 trial: The utility of FDG-PET in staging potentially operable non-small cell lung cancer (vol 126, pg 1943, 2003).” Journal of Thoracic and Cardiovascular Surgery. MOSBY-ELSEVIER, April 1, 2007.
       Link to Item
    • Potti, Anil, David H. Harpole, and Joseph R. Nevins. “Refining prognosis in non-small-cell lung cancer - Reply.” New England Journal of Medicine. MASSACHUSETTS MEDICAL SOC, January 11, 2007.
       Link to Item
    • Potti, Anil, Holly K. Dressman, Andrea Bild, Richard F. Riedel, Gina Chan, Robyn Sayer, Janiel Cragun, et al. “Genomic signatures to guide the use of chemotherapeutics.” Nat Med, November 2006. https://doi.org/10.1038/nm1491.
       Full Text  Link to Item
    • Rice, David C., Jeremy J. Erasmus, Craig W. Stevens, Ara A. Vaporciyan, Judy S. Wu, Anne S. Tsao, Garrett L. Walsh, et al. “Extended surgical staging for potentially resectable malignant pleural mesothelioma.” Ann Thorac Surg, December 2005. https://doi.org/10.1016/j.athoracsur.2005.06.014.
       Full Text  Link to Item
    • Vaporciyan, Ara A., Arlene M. Correa, David C. Rice, Jack A. Roth, W. R. Smythe, Stephen G. Swisher, Garrett L. Walsh, and Joe B. Putnam. “Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patients.” J Thorac Cardiovasc Surg, March 2004. https://doi.org/10.1016/j.jtcvs.2003.07.011.
       Full Text  Link to Item
    • Nguyen, Dao M., G Aaron Chen, Rishindra Reddy, Wilson Tsai, William D. Schrump, George Cole, and David S. Schrump. “Potentiation of paclitaxel cytotoxicity in lung and esophageal cancer cells by pharmacologic inhibition of the phosphoinositide 3-kinase/protein kinase B (Akt)-mediated signaling pathway.” J Thorac Cardiovasc Surg, February 2004. https://doi.org/10.1016/j.jtcvs.2003.09.033.
       Full Text  Link to Item
    • Mackensen, G. B., L. K. Ti, B. G. Phillips-Bute, J. P. Mathew, M. F. Newman, H. P. Grocott, and H. P. Neurologic Outcome Research Group (NORG). “Cerebral embolization during cardiac surgery: impact of aortic atheroma burden.” Br J Anaesth, November 2003. https://doi.org/10.1093/bja/aeg234.
       Full Text  Link to Item
    • Petre, Paul M., Frank A. Baciewicz, Stefan Tigan, and J Richard Spears. “Hyperbaric oxygen as a chemotherapy adjuvant in the treatment of metastatic lung tumors in a rat model.” J Thorac Cardiovasc Surg, January 2003. https://doi.org/10.1067/mtc.2003.90.
       Full Text  Link to Item
    • Swaminathan, Madhav, Brian J. McCreath, Barbara G. Phillips-Bute, Mark F. Newman, Joseph P. Mathew, Peter K. Smith, James A. Blumenthal, Mark Stafford-Smith, and Mark Perioperative Outcomes Research Group. “Serum creatinine patterns in coronary bypass surgery patients with and without postoperative cognitive dysfunction.” Anesth Analg, July 2002. https://doi.org/10.1097/00000539-200207000-00001.
       Full Text  Link to Item
    • Grigore, Alina M., Hilary P. Grocott, Joseph P. Mathew, Barbara Phillips-Bute, Timothy O. Stanley, Aimee Butler, Kevin P. Landolfo, et al. “The rewarming rate and increased peak temperature alter neurocognitive outcome after cardiac surgery.” Anesth Analg, January 2002. https://doi.org/10.1097/00000539-200201000-00002.
       Full Text  Link to Item
    • Harpole, David H. “Invited commentary.” The Annals of Thoracic Surgery. Elsevier BV, August 2000. https://doi.org/10.1016/s0003-4975(00)01549-6.
       Full Text
    • Kwiatkowski, D. J., D. H. Harpole, J. Godlewski, J. E. Herndon, D. B. Shieh, W. Richards, R. Blanco, H. J. Xu, G. M. Strauss, and D. J. Sugarbaker. “Molecular pathologic substaging in 244 stage I non-small-cell lung cancer patients: Clinical implications.” Pneumologie, December 1, 1999.
    • Harpole, D. H. “Prognostic significance of HER-2/neu overexpression in stage I adenocarcinoma of lung.” Annals of Thoracic Surgery. ELSEVIER SCIENCE INC, October 1, 1998.
       Link to Item
    • Miller, D. L., D. H. Harpole, and H. I. Pass. “Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer - Discussion.” Annals of Thoracic Surgery. ELSEVIER SCIENCE INC, May 1, 1996.
       Link to Item

  • Conference Papers

    • Raman, Vignesh, Oliver K. Jawitz, Chi-Fu Jeffrey Yang, Soraya L. Voigt, Thomas A. D’Amico, David H. Harpole, and Betty C. Tong. “The effect of extent of resection on outcomes in patients with limited stage small cell lung cancer.” In J Thorac Cardiovasc Surg, 161:1484-1492.e5, 2021. https://doi.org/10.1016/j.jtcvs.2020.02.135.
       Full Text  Link to Item
    • Farrow, Norma E., Selena J. An, Paul J. Speicher, David H. Harpole, Thomas A. D’Amico, Jacob A. Klapper, Matthew G. Hartwig, and Betty C. Tong. “Disparities in guideline-concordant treatment for node-positive, non-small cell lung cancer following surgery.” In J Thorac Cardiovasc Surg, 160:261-271.e1, 2020. https://doi.org/10.1016/j.jtcvs.2019.10.102.
       Full Text  Link to Item
    • Raman, Vignesh, Oliver K. Jawitz, Soraya L. Voigt, Chi-Fu J. Yang, David H. Harpole, Thomas A. D’Amico, and Matthew G. Hartwig. “The effect of age on survival after endoscopic resection versus surgery for T1a esophageal cancer.” In J Thorac Cardiovasc Surg, 160:295-302.e3, 2020. https://doi.org/10.1016/j.jtcvs.2019.11.050.
       Full Text  Link to Item
    • Yu, Hui, Daniel T. Merrick, Ming-Sound Tsao, William G. Richards, Lucian R. Chirieac, Mark A. Watson, Christopher J. Rivard, et al. “Abstract 4550: Correlations between tumor mutation burden, inflammatory profile and histological characteristics of tumor microenvironment in early-stage squamous cell lung carcinoma.” In Tumor Biology. American Association for Cancer Research, 2019. https://doi.org/10.1158/1538-7445.sabcs18-4550.
       Full Text
    • Kröhnert, M., R. Anderson, J. Bumberger, P. Dietrich, W. S. Harpole, and H. G. Maas. “Watching grass grow - A pilot study on the suitability of photogrammetric techniques for quantifying change in Aboveground Biomass in Grassland experiments.” In International Archives of the Photogrammetry, Remote Sensing and Spatial Information Sciences  Isprs Archives, 42:539–42, 2018. https://doi.org/10.5194/isprs-archives-XLII-2-539-2018.
       Full Text
    • Maddula, Krishna, Mary-Beth Joshi, Vijay Modur, and David H. Harpole. “Abstract 1904: RNA expression based screening of ALK gene fusion from formalin fixed non-small cell lung cancer samples.” In Clinical Research (Excluding Clinical Trials). American Association for Cancer Research, 2014. https://doi.org/10.1158/1538-7445.am2014-1904.
       Full Text
    • Grogan, Eric L., Stephen A. Deppen, Heidi Chen, Karla V. Ballman, Francys C. Verdial, Melinda C. Aldrich, Paul A. Decker, et al. “Abstract LB-296: FDG-PET avidity negatively impacts survival in pStage I NSCLC in the ACOSOG Z4031 trial.” In Clinical Research. American Association for Cancer Research, 2013. https://doi.org/10.1158/1538-7445.am2013-lb-296.
       Full Text
    • Higgins, Kristin A., Neal E. Ready, Thomas A. D’amico, Mark W. Onaitis, Jeffrey Crawford, Robert Clough, Mark F. Berry, et al. “PERSISTENT N2 DISEASE AFTER NEOADJUVANT CHEMOTHERAPY-NOW WHAT?” In Journal of Thoracic Oncology, 6:S1572–S1572. LIPPINCOTT WILLIAMS & WILKINS, 2011.
       Link to Item
    • Joshi, Marybeth M., Loretta Erhunmwunsee, Debbi H. Conlon, and David H. Harpole. “NEIGHBORHOOD-LEVEL SOCIOECONOMIC (SES) DETERMINANTS NEGATIVELY IMPACT TREATMENT DECISIONS AMONG NON-SMALL CELL LUNG CANCER PATIENTS IN THE SOUTHEASTERN UNITED STATES.” In Journal of Thoracic Oncology, 6:S327–28. LIPPINCOTT WILLIAMS & WILKINS, 2011.
       Link to Item
    • Patel, P. R., S. Yoo, L. Marks, E. Miles, T. A. D’Amico, D. H. Harpole, and C. Kelsey. “The Effect of Increasing Experience with Intensity Modulated Radiation Therapy for Resected Malignant Pleural Mesothelioma.” In International Journal of Radiation Oncology*Biology*Physics, 78:S505–6. Elsevier BV, 2010. https://doi.org/10.1016/j.ijrobp.2010.07.1181.
       Full Text
    • Erhunmwunsee, Loretta, Sandra S. Stinnett, and David H. Harpole. “Socioeconomic status predicts outcomes from NSCLC.” In Journal of Thoracic Oncology, 4:S310–11. LIPPINCOTT WILLIAMS & WILKINS, 2009.
       Link to Item
    • Gandara, David R., Philip C. Mack, Akiko Omori, Peter Grimminger, Mary-Beth M. Joshi, David H. Harpole, and Kathleen D. Danenberg. “Ribonucleotide reductase (RRM1) expression in non-small cell lung cancer (NSCLC): implications for personalizing gemcitabine-based therapy.” In Journal of Thoracic Oncology, 4:S401–2. LIPPINCOTT WILLIAMS & WILKINS, 2009.
       Link to Item
    • Gandara, David R., Philip C. Mack, Akiko Omori, Peter Grimminger, Primo N. Lara, Mary-Beth M. Joshi, David H. Harpole, and Kathleen D. Danenberg. “Thymidylate synthase (TS) RNA expression in non-small cell lung cancer (NSCLC): implications for personalizing pemetrexed therapy.” In Journal of Thoracic Oncology, 4:S400–S400. LIPPINCOTT WILLIAMS & WILKINS, 2009.
       Link to Item
    • Joshi, Mary-Beth M., Bruce Seligmann, and David H. Harpole. “Measurement of gene expression biomarkers by qNPA (TM) from archived NSCLC FFPE: prognosis of 5-year survival.” In Journal of Thoracic Oncology, 4:S502–S502. LIPPINCOTT WILLIAMS & WILKINS, 2009.
       Link to Item
    • Mack, Philip C., David R. Gandara, Akiko Omori, Peter P. Grimminger, Heinz-Josef Lenz, Mary-Beth M. Joshi, David H. Harpole, and Kathleeen D. Danenberg. “KRAS mutation analysis in non-small cell lung cancer (NSCLC) versus colorectal cancer (CRC): implications for EGFR-directed therapies.” In Journal of Thoracic Oncology, 4:S350–S350. LIPPINCOTT WILLIAMS & WILKINS, 2009.
       Link to Item
    • Erhunmwunsee, Loretta, Yun Lu, Xiaoyan Luo, David H. Harpole, Brigid L. M. Hogan, and Mark W. Onaitis. “Basal cells in lung cancer.” In Journal of the American College of Surgeons, 207:S30–S30. Elsevier BV, 2008. https://doi.org/10.1016/j.jamcollsurg.2008.06.053.
       Full Text
    • Kelsey, C. R., J. A. Boyd, J. L. Hubbs, D. R. Hollis, J. Crawford, N. E. Ready, T. A. D’Amcio, D. H. Harpole, J. Garst, and L. B. Marks. “Local/regional recurrence following surgery for early-stage lung cancer: A 10-year experience with 975 patients.” In Journal of Clinical Oncology, Vol. 26. AMER SOC CLINICAL ONCOLOGY, 2008.
       Link to Item
    • Oh, D. S., J. Cooc, S. R. DeMeester, R. Mori, H. Kuramochi, C. Rizzetto, K. Danenberg, et al. “Molecular signature of esophageal adenocarcinoma derived from microarray analysis of paraffin-embedded specimens predicts systemic recurrence following resection.” In Journal of Clinical Oncology, Vol. 25. AMER SOC CLINICAL ONCOLOGY, 2007.
       Link to Item
    • Huening, M. A., D. W. Sevilla, A. Potti, D. H. Harpole, J. R. Nevins, and M. B. Datto. “A first step towards validating microarray gene expression profiling for clinical testing: Characterizing biological variance.” In Journal of Molecular Diagnostics, 8:660–660. AMER SOC INVESTIGATIVE PATHOLOGY, INC, 2006.
       Link to Item
    • Harpole, D. H., M. M. Joshi, R. P. Petersen, D. H. Conlon, K. Tanaka, D. Shimizu, H. Kuramochi, M. Williams, P. V. Danenberg, and K. Danenberg. “A lung cancer genomic risk prediction model derived from paraffin-embedded tissue.” In Journal of Clinical Oncology, 24:555S-555S. AMER SOC CLINICAL ONCOLOGY, 2006.
       Link to Item
    • Harpole, D. H., R. Petersen, S. Mukherjee, A. Bild, H. Dressman, R. Kratzke, M. J. Kelley, et al. “A genomic strategy to refine prognosis in early stage non-small cell lung carcinoma (NSCLC).” In Journal of Clinical Oncology, 24:370S-370S. AMER SOC CLINICAL ONCOLOGY, 2006.
       Link to Item
    • Joshi, M. M., R. P. Petersen, D. H. Conlon, K. Tanaka, D. Shimizu, H. Kuramochi, M. Williams, P. V. Danenberg, K. D. Danenberg, and D. H. Harpole. “Differential canonical pathways derived from microarrays using RNA from paraffin-embedded non-small cell lung cancer tissue.” In Journal of Clinical Oncology, 24:420S-420S. AMER SOC CLINICAL ONCOLOGY, 2006.
       Link to Item
    • Jaklitsch, M. T., L. Gu, D. H. Harpole, T. A. D’Amico, R. J. McKenna, M. J. Krasna, L. J. Kohman, S. J. Swanson, M. M. Decamp, and D. J. Sugarbaker. “Prospective phase II trial of pre-resection thoracoscopic (VATS) restaging following neoadjuvant therapy for IIIA(N2) non-small cell lung cancer (NSCLC): Results of CALGB 39803.” In Journal of Clinical Oncology, 23:636S-636S. AMER SOC CLINICAL ONCOLOGY, 2005.
       Link to Item
    • Petersen, R. P., A. Bild, H. Dressman, M. B. M. Joshi, D. H. Conlon, M. West, J. R. Nevins, and D. H. Harpole. “Gene expression signatures for prognosis in NSCLC, coupled with signatures of oncogenic pathway deregulation, provide a novel approach for selection of molecular targets.” In Journal of Clinical Oncology, 23:626S-626S. AMER SOC CLINICAL ONCOLOGY, 2005.
       Link to Item
    • Lemaire, Anthony, William R. Burfeind, Stafford S. Balderson, David H. Harpole, and Thomas A. D’Amico. “Tracheobronchial Stents in Selected Patients with Benign Airway Disease.” In Chest, 126:801S-801S. Elsevier BV, 2004. https://doi.org/10.1378/chest.126.4_meetingabstracts.801s.
       Full Text
    • Strauss, G. M., J. E. Herndon, M. A. Maddaus, D. W. Johnstone, E. A. Johnson, D. H. Harpole, H. H. Gillenwater, et al. “A randomized clinical trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in stage IB non-small cell hung cancer (NSCLC): report of cancer and leukemia group b (CALGB) protocol 9633.” In Lung Cancer, 45:S75–76. ELSEVIER SCI IRELAND LTD, 2004.
       Link to Item
    • Strauss, Gary M., James E. Herndon, Michael A. Maddaus, David W. Johnstone, Elizabeth A. Johnson, David H. Harpole, Heidi H. Gillenwater, et al. “Randomized clinical trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in stage IB non-small cell lung cancer (NSCLC): Report of Cancer and Leukemia Group B (CALGB) Protocol 9633.” In Annals of Oncology, 15:13–14. OXFORD UNIV PRESS, 2004.
       Link to Item
    • Gaca, J. G., D. H. Harpole, T. A. D’Amico, T. Pappas, H. F. Seigler, W. G. Wolfe, and S. Tyler. “Pathologic nodal status predicts disease-free survival after neoadjuvant chemoradiation for gastroesophageal junction carcinoma.” In Gastroenterology, 123:1–2. W B SAUNDERS CO, 2002.
       Link to Item
    • Aloia, T., H. P. McAdams, G. Bepler, D. H. Harpole, P. C. Goodman, and E. F. Patz. “Integration of peripheral blood biomarkers with CT to differentiate benign from malignant pulmonary opacities.” In Radiology, 217:469–469. RADIOLOGICAL SOC NORTH AMER, 2000.
       Link to Item
    • Jaklitsch, M. T., M. M. Decamp, M. J. Liptay, D. H. Harpole, S. J. Swanson, S. J. Mentzer, and D. J. Sugarbaker. “Video-assisted thoracic surgery in the elderly. A review of 307 cases.” In International Congress of Thorax Surgery, edited by G. Antypas, 599–601. MONDUZZI EDITORE, 1997.
       Link to Item
    • HARPOLE, D. H. “RESECTION OF PULMONARY BULLOUS CYSTS WITH YAG LASER.” In Lasers in Surgery and Medicine, 8:195–195. WILEY-LISS, 1988.
       Link to Item

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.